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Introduction 
Nanotechnology is a promising research area in many fields, as for example 
energy, environmental applications as well as medicine. In pharmaceutical research 
the use of nanotechnology is of great interest for the possibilities it offers to control 
drug delivery and to vehicle poor water-soluble drugs or macromolecules, like 
proteins, peptides or nucleic acids.  
Historically, the development of nanoparticles of different kind (liposomes, 
polymeric nanoparticles, etc.) in drug therapy was initiated in order to improve 
drug efficacy as much as possible. Drug activity mainly depends on its 
concentration at the active site, as well as many side effects depend on its 
concentration in healthy organs or tissues. In turn, drug distribution in the body 
depends on the physicochemical properties of the drug, so that the drug might have 
no affinity with the diseased area; the use of a nanocarrier to vehicle the drug can 
overcome this problem. The carrier can, in fact, accumulate selectively at the target 
tissue (passive targeting). The carrier can also be bound with a specific molecule 
(usually an antibody) which has high selectivity for the target cell (active targeting). 
The use of a carrier can also modify the time of release of the drug, allowing to 
obtain a continue release of the drug which guarantees therapeutic concentration of 
the drug in the target site for an extended period of time. 
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The size of these particulate carriers is fundamental because it determines the 
route of administration of the drug. If too big (usually > 1 µm) they cannot be 
administrated by the traditional route (intravenous for example) because capillaries 
would be blocked and the carrier should be implanted near the target tissue. For 
this and other reasons it is important that the size of these systems is in the range of 
nanometers.  
Nanocarriers are typically liposomes or nanoparticles, but new carriers are 
being developed both for treatment and diagnostic scope. The formulation of 
polymers suitable for pharmaceutical applications (which have to be biodegradable 
and biocompatible) is another important field of exploration, together with the 
development of new and more efficient ways to produce these carriers 
The aim of this work is to characterize two particular classes of carriers, 
nanocapsules and nanospheres obtained from an amphiphilic copolymer of the 
cyanoacrylates family, in continuous micromixers. The work comprises the 
characterization of the polymer, the investigation of the different process 
parameters, processes design  and scale up and final particle characterization.  
This thesis is organized as follows.  
Firstly, in Chapter 2, the characterization of the polymer is shown. The 
polymer was characterized in terms of its physicochemical characteristics and 
degradation time. 
Then nanocapsules production in CIJMs is discussed (Chapter 3). 
In Chapter 4 the effect of the main parameters involved in the production 
process are studied and scale up criteria are suggested. 
Advanced characterization through X-ray Photon Electron Spectroscopy (XPS) 
and Transmission Electron Microscopy (TEM) on nanocapsules and nanospheres is 
shown in Chapter 5.  
Results related to loaded nanocapsules and nanospheres with a model drug 
are reported in Chapter 6. Results include release and anti-bacterial tests. 
Conclusions about the system studied and the collected results are 
summarized in Chapter 7. 
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1. Theoretical background and state of the art 
1.1. Pharmaceutical nanocarriers 
Pharmaceutical carriers refer to any systems capable to act as a vehicle for 
active compounds in therapy. In recent years carriers with size in the nanometers 
range have attracted the interest of researchers and of the pharma industry thanks 
to their ability to be injected through the general routes of administration without 
the risk of blocking the blood stream in the capillaries. Carriers in the nanometers 
range are usually referred to as nanoparticles. Nanoparticles are colloidal systems 
with particle diameters between 1 and 1000 nm where the drug can be 
encapsulated, adsorbed or dispersed in them. A wide range of materials have been 
studied in drug delivery, including lipids, polymers and inorganic materials. The 
growing interest towards these systems is due to their ability to modify drug 
delivery. As already mentioned, the nano-size range allows to inject them directly in 
the blood stream; moreover it was seen that smaller dimensions reduce the 
opsonization phenomenon and the subsequent phagocytosis by macrophages as 
well as it reduces the rate of clearance (the rate the kidney has to purify the blood 
from external components). At the same time circulation time can be increased by 
binding to the surface hydrophilic molecules such as polyethylene glycol (PEG), 
because it creates an aqueous shell around the particles which avoids the adhesion 
of the opsonins on particle surface. Small size and enhanced circulation time lead to 
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an increased accumulation of the particles (and obviously of the entrapped drug) in 
tissues with increased vascular permeability and lymphatic drainage such as 
tumours and inflamed tissues. This phenomenon, named as enhanced permeability 
and retention (EPR) effect, is exploited as a way of passive targeting (Figure 1.1.1).  
 
Figure 1.1. Blood vessels and lymphatic drainage in a normal tissue and in a diseased tissue: red 
squares represent the particles, which accumulate more in the diseased tissue. 
In the last 30 years nanotechnology has been studied in particular for the 
treatment of complex diseases, such cancer, infections, metabolic diseases, 
autoimmune diseases and inflammation. Today some of these systems are already 
marketed and widely used (Caelyx®, Ambisome®, which are both liposomes) and 
others are in clinical trials. It has to be noted that liposomes are made of 
phospholipids, the natural component of cell membrane, whereas nanoparticles are 
made of polymers. 
Nanoparticles composed of biocompatible polymers have been widely 
investigated in order to use them as drug delivery systems. They offer the 
advantage they can be used to vehicle hydrophobic drugs via solubilization in the 
hydrophobic core of the particles. Polymeric nanoparticles can be distinguished in 
nanospheres and nanocapsules. Nanospheres and nanocapsules can be prepared by 
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polymerization in situ or from a preformed polymer. The second type of preparation 
offers some advantages: polymer physicochemical characteristics are well defined 
and there are not residual monomers in the medium. 
1.1.1. Nanospheres  
Nanospheres are constituted by the polymer which forms a solid matrix 
usually defined as a monolithic system (homogeneous). In this system the polymer 
chains arranges in a “frozen” state phase-separated from the bulk solution. In case 
the polymer is an amphiphilic copolymer, hydrophobic chains should form the 
inner part of the particle, whereas the hydrophilic part goes on the surface of the 
particle. 
Drugs can be dissolved, entrapped, encapsulated, chemically bound or 
adsorbed to the constituent polymer matrix.  
Nanospheres can be prepared by polymerization in situ or from a preformed 
polymer. In the first case nanospheres can be obtained by emulsion polymerization 
or by interfacial polymerization. For preformed polymers, nanospheres preparation 
can be achieved by emulsification/solvent evaporation, emulsification/solvent 
diffusion and salting out techniques, but the most common one is solvent 
displacement, also called nanoprecipitation. In this method the polymer is dissolved 
in an organic water-soluble solvent, which is then added to an anti-solvent, usually 
water, which can contain or not a surfactant and other additives. The solvent 
immediately diffuses in the aqueous phase leading to the polymer precipitation and 
nanosphere formation. 
1.1.2. Nanocapsules  
Nanocapsules are colloidal-sized, vesicular system (heterogeneous) in which 
the drug is confined to a reservoir surrounded by the polymer. The core is a 
lipophilic liquid surrounded by a single layer of polymer. Nanocapsules are useful 
to vehicle hydrophobic drugs, since drugs are dissolved in the liquid core and can 
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be loaded in high quantity. Nanocapsules have some advantages over nanospheres, 
because they require a lower amount of polymer for each particle and as 
consequence drug loading as percentage of polymer content is higher. Moreover, 
drug solubility can be greatly increased varying the inner liquid.  
Nanocapsules, like nanospheres, can be either obtained following an 
interfacial polymerization of monomers or from preformed polymers. In the former 
case, the molecular weight of the final polymer will depend on the preparation 
conditions and also on the drug used, while in the latter polymer characteristics are 
well defined. They are usually produced by nanoprecipitation, where drug, 
polymer and oil are dissolved in the solvent and then added to the aqueous phase. 
They can be produced also by emulsion-diffusion method and emulsion-
coacervation method. 
In Figure 1.2 a graphic representation of nanosphere and nanocapsule by an 
amphiphilic copolymer, with hydrophilic chains stretched out is shown. 
Figure 1.2. Representation of a nanospheres and of a nanocapsules made of an amphiphilic 
copolymer: blue part is the hydrophobic part, green part is the hydrophilic one. 
1.2. Polymers 
Polymers are widely used in drug delivery thanks to some specific qualities 
they have. They can be manipulated in many ways, by increasing their chain length 
through cross-linking or by hydrophobising or hydrophilizing them with polymers 
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and other groups, yielding a wealth of materials with a wide spectrum of possible 
applications. The resulting materials are capable of a variety of drug-enhancing 
functions: 
• to prolong drug availability; 
• to favorably alter biodistribution if formulated into dense nanoparticles; 
• to enable hydrophobic drug administration if formulated as micelles; 
• to transport a drug to its usually inaccessible site of action if formulated as gene 
medicines; 
• to make drugs available in response to stimuli. 
Great attention is given to the biodegradability and biocompatibility of the 
polymers. It is important that polymers used in medicine are not dangerous for 
tissue and that they can be eliminated by the human body without producing 
dangerous molecules.  
1.2.1. Cyanoacrylates 
The use of poly(alkylcyanoacrylates) (PACAs) started in the early 80s, even if 
the monomers have been used since the 60s thanks to their adhesive properties. 
They were used as tissue adhesive, as surgical glue and embolitic material for 
endovascular surgery. In 80s, together with the rise of drug nanoparticulate carriers, 
PACAs particles started to be investigated. As said before, monomers were firstly 
employed in biomedical field, mainly for skin wound closure. Early cyanoacrylates, 
as methylcyanoacrylate, are not in use anymore, except for some cases, and were 
replaced by longer-chains alkylcyanoacrylates such as N-butylcyanoacrylate and 
octylcyanoacrylate.  
PACAs were widely used in the production of nanoparticles for drug delivery. 
Polyisobutylcyanoacrylates and poly(isohexylcyanoacrylate) are two of the most 
commonly used. PACAs were bound and modified with different molecules, such 
as polyethylene glycol (PEG), polysaccharides (Chauvierrea et al., 2010) and folic 
acid (Stella et al., 2007 ). Modifying polymer molecules with PEG chains is very 
common in pharmaceutical applications to obtain “stealth” nanoparticles, because 
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long PEG chains create an aqueous shell around the particles, avoiding 
nanoparticles to be recognized and rapidly eliminated from blood circulation by the 
Reticulo Endothelial System (RES). They are bioerodible polymers: the main path of 
degradation is the hydrolysis of the ester bond of the alkyl side chain of the 
polymer. 
1.2.2. P(MePEGCA-co-HDCA) 
P(methoxypolyethyleneglycol cyanoacrylate-co-hexadecyl cyanoacrylate) is an 
amphiphilic block co-polymer which was synthesized for the first time by Peracchia 
et al. (1997). It was studied to provide the characteristics of long-chains 
cyanoacrylates and the advantages of PEG chains to give amphiphilic properties 
and increase blood lifetime of nanoparticles. This copolymer was synthesized by a 
single-step condensation of cyanoacetate monomers with formaldehyde, as 
described in details in Chapter 2. The copolymer was produced at different 
hexadecyl/PEG chains ratio in order to investigate the effect of the different 
hydrophilic level on polymer charatcteristics. The more suitable for pharmaceutical 
application in nanoparticles preparation resulted to be the one with a 
hexadecyl/PEG ratio of 4:1. In this ratio it has a good balance between thydrophility 
and lipophilicity, so that it is not miscible in water, but at the same time is miscible 
in water-miscible solvents.  
 
 
Figure 1.3. Poly(methoxypolyethyleneglycole cyanoacrylate-co-hexadecyl cyanoacrylate) formula. 
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Several studies (see for example Peracchia et al. 1998) show that PEG-coating 
reduces cytotoxicity towards mouse peritoneal macrophage and increases 
degradability of the polymer in presence of calf serum. 
The molecular weight of the copolymer synthesized with a ratio 4:1 was 
measured to be 3.5 kDa. Since the molecular weight of PEG chains used in the 
synthesis is of 2000 D, it is reasonable to think that the macromolecules within this 
range are oligomers. As highilighted in Brigger et al. (2000) the final ratio 4:1 is only 
a mean value of different molecular species: in each copolymer batch more 
lipophilic oligomers (with a higher hexadecyl chains content) or more hydrophilic 
oligomers (with a higher MePEG chains) might be present. 
1.3. Production processes 
Polymer nanospheres and nanocapsules can be prepared both by 
polymerization methods (Bouchemal et al., 2006, Pitaksuteepong et al., 2002) and 
from a preformed polymer, by different mechanisms such as solvent-displacement 
(Peracchia et al., 1998), emulsion-diffusion (Moinard-Checot et al., 2008), double-
emulsification (Garti, 1997). The different processes and the characteristics of the 
nanocapsules produced have been recently compared (Mora-Huertas et al., 2010). In 
the first way (polymerization method) particle formation follows immediately the 
polymerization of the monomers. This method is now less used because it presents 
some limitations: polymer characteristics are not well defined and it is possible to 
have residual monomers in the solution. For this reason the synthesis of 
nanoparticles from a preformed polymer is now preferred and widely used. 
The most common route for nanosphere and nanocapsule production are 
solvent-displacement, also called nanoprecipitation, emulsification-solvent diffusion 
method and emulsification-solvent evaporation method, as said before. The right 
method for a specific preparation depends on the type of solvent used. Rieger et 
Horn (2001) give the following guidelines: 
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1. Emulsion-evaporation method is used with lipophilic solvents and particle 
formation occurs through an emulsion step. Polymeric particles are formed 
inside the organic drops (o/w emulsion) and the solvent is separated by 
evaporation. 
2. Emulsion-diffusion method is used with amphiphilic solvents and the 
emulsion is transient and then transforms into a nanodispersion. 
3. Solvent-displacement method is used with hydrophilic solvents and particle 
formation occurs by nanoprecipitation through either nucleation and growth 
steps or through spinodal decomposition. 
In this thesis, solvent-displacement is used. It will be described in details in 
Chapter 3. 
1.3.1. Micromixers 
Microdevices refer to systems with characteristic length-scales from the 
micrometer to the millimeter range. These devices allow to control the process 
conditions and are characterized by good and fast homogenization of the feed 
streams, short mean residence time and narrow residence time distribution. 
Two different principles can be followed to produce mixing at the microscale. 
Firstly, by using an energy input from the exterior (active mixing). Ultrasound, 
acoustic, bubble-induced vibrations, periodic variations of flow rate, magneto-
hydrodynamic action, etc. can be used as external energy sources. 
Otherwise, the flow energy, generated by pump action or hydrostatic 
potential, is used to restructure a flow in a way which results in faster mixing: this 
second means is named passive mixing.  
In passive mixing, Y- and T-flow geometries are the main examples. There are 
other ways to produce mixing in a microdevice. Confined impinging jets mixers 
(CIJMs) consist of two high velocity jets which collide in a small chamber, providing 
good and fast mixing. Chamber size and inlet jets diameters affect mixing efficiency. 
Their use in nanoprecipitation for pharmaceutical application is interesting since 
they allow to control final particle size modifying some parameters, such as the inlet 
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jet velocity or geometrical details, such as the ratio between chamber diameter and 
inlet jet (Δ).  
CIJMs were highly studied in nanoprecipitation processes because they result 
in mixing times shorter than the characteristic process time for nanoprecipitation. 
Rapid mixing is measured in CIJMs for two reasons (Johnson and Prud’homme, 
2003): they produce a region of high turbulent energy  dissipation and ensure that 
the process streams flow through the high intensity region without bypassing. 
A different geometry is the multi inlet vortex mixer (MIVM), where a variable 
number of inlet jets (usually from 2 to 4) are fed tangentially in a cylindrical mixing 
chamber. Differently from CIJMs, in MIVMs it is not necessary that the inlet streams 
have the same momenta in order to provide good mixing. Thanks to this, MIVMs 
offer more possibilities, because different inlet streams can be fed at different flow 
rates without affecting mixing performance.   
These geometries are reported in Figure 1.4. 
 
Figure 1.4. Section view of some kind of passive mixing devices used in this thesis: a) T-mixer, 
b)CIJM (front view), c) MIVM with 2 inlet jets (above view) and d) MIVM with 4 inlet jets (above 
view). 
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The work is focused on the use of CIJMs of different size and geometry 
(Chapter 3). Some experiments are performed in vortex mixers, while in Chapter 4 
some data from previous work in CIJMs and Tee-mixers are used to discuss on 
design and scale up criteria of micromixers.  
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2. Characterization of the polymer 
2.1. Introduction 
Several works have been focused on the preparation of nanoparticles from 
poly(MePEGCA-co-HDCA) with a hydrophilic/hydrophobic ratio of one to four by 
nanoprecipitation and by emulsion/solvent evaporation methods (Peracchia et al., 
1997, Peracchia et al., 1998). In general, unimodal size distributions were obtained 
with the mean diameter ranging between 98 and 199 nm and varying in function of 
the polymer concentration and the applied method. It was also demonstrated that 
nanoparticles had an adequate density of MePEG chains on their surface to provide 
enhanced stability in the blood stream and to ensure long circulating times 
(Peracchia et al., 1999, Brigger et al., 2000). 
This chapter is focused on physicochemical characterization of the polymer, 
with respect to thermal, morphological and crystalline aspects and degradability.  
2.2. Synthesis 
In this work the amphiphilic poly(methoxy-polyethylene glycol)-co-hexadecyl-
cyanoacrylate (P(MePEGCA-co-HDCA)) was used for the preparation of stealth 
nanoaprticles for pharmaceutical applications. It was synthesized, following the 
procedure of Peracchia et al. (1997) with some minor changes. The standard 
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synthesis proposes the use of a base-catalyzed condensation of MePEG cyanoacetate 
(MePEGCA) and cyanoacetic acid with formaldehyde. This kind of 
condensation/polymerization involve a Michael addition as the step-growth 
mechanism, where the steric hindrance determines the chain lengths. The use of 
cyanoacetate monomers allows better control of the polymerization process in 
comparison to the use of the cyanoacrylate monomers, which react very fast in 
presence of bases and other nucleophilic agents. 
2.2.1. Materials 
Poly(ethylen-glycol) methyl ether (MePEG), with avarage molecular weight 
2000 D, was purchased from Sigma Aldrich, whereas 1-hexadecanol and 
cyanoacetic acid (CA) from Fluka Chemika. All other reagents were of analytical 
grade from Sigma-Aldrich but the solvents from Carlo Erba. 
2.2.2. Preparation of the monomers 
The two monomers were prepared by esterification of the cyanoacetic acid 
with the corresponding alchol (polyethylenglycole-methyl ether and hexadecanol) 
following the methodology reported by Peracchia et al. (1997). 
MePEG cyanoacetate (MePEGCA) was synthesized by esterification of MePEG 
(22 g, 11 mmol) and cyanoacetic acid (ACA, 1.87 g, 22 mmol) in the presence of N-
(3-dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC) and 
(dymethylamino)pyridine (DMAP) as catalyst. The two reagents were dissolved in 
dichloromethan (DCM, molar ratio acid/MePEG 2:1) and then EDC (4.22 g, 11 
mmol) and DMAP (0.134 g) were added. The reaction was carried at room 
temperature in nitrogen atmosphere, stirring for 24 hours. After this time it was 
washed with six 25 ml portions of water. The organic phase was collected and dried 
over magnesium sulphate (MgSO4). Then it was filtered and concentrated under 
reduced pressure to leave a viscous oil which solidified on standing. 
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Figure 2.1. Synthesis of MePEGCA. 
n-Hexadecylcyanoacetate (HDCA) was synthesized by esterification of n-
hexadecanol (10 g, 41,2 mmol) and cyanoacetic acid (3.87 g, 45.4 mmol). 
Hexadecanol was dissolved in 100 ml DCM, while ACA was dissolved in the 
necessary volume of ethyl acetate and then added to the solution of hexadecanol in 
DCM. DMAP was dissolved in DCM and added. 1,3-dicyclohexylcarbodiimide 
(DCC, 9.35 g) was dissolved in DCM and added by dropping to the reaction 
mixture. The reaction was stirred at room temperature at nitrogen atmosphere for 2 
hours. 
Hexane is added to the mixture and the white solid that formed was filtered 
off. The mixture was then purified by flash chromatography (silica gel 60, 230-400 
mesh) using hexane/ethyl acetate (90:10) as eluting phase. The product was 
collected and concentrated under reduced pression. 
 
Figure 2.2. Synthesis of HDCA. 
2.2.3. Condensation/Polymerization of the monomers 
The two monomers were condensed using formaldehyde as polymerization 
agent, in a respective molar ratio 1:4 for MePEGCA and HDCA.  
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MePEGCA (10.34 g, 5 mmol) and HDCA (6.18 20 mmol) were previously 
dissolved separately in 50 ml of DCM. Then they were mixed together and 50 ml 
ethanol were added. Then formaldehyde 37% was added in excess (6.08 ml, 75 
mmol) in order to guarantee 100% of polymerization. Finally dymethylammine 
(DMA, 8,44 ml) was added and the reaction was left on stirring in nitrogen 
atmosphere until complete consumption of the two monomers (seen through thin 
layer cromathography, TLC). 
The mixture was washed firstly with 30 ml chloridric acid 1 N and then 2 times 
with 30 ml water. The organic phase was collected and dried over MgSO4. Then it 
was filtered and concentrated under reduced pressure to give the final product. 
 
Figure 2.3. Polymerization reaction. 
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2.3. Physicochemical characterization 
2.3.1. Measurements 
Solubility evaluation of the as-synthesized polymer in the different solvents 
are present in literature (Peracchia et al., 1997). In this work the solubility of the 
polymer was studied in the water/acetone mixture. The experiments were 
performed at 30 ºC and the solubility was measured by evaluating the turbidity of 
copolymer solution, after addition of controlled amounts of water to the acetone 
polymer solution. The water fraction investigated were 50%, 66% and 90%. As it 
will be explained in Chapter 3, 50% fraction and 66% fraction correspond to the 
solvent-antisolvent mixture obtained when working without quenching and with 
quenching, respectively. Many acetone solutions at different concentrations were 
diluted with water at the three value indicated before. Final concentration of the 
polymer was then recalculated. In this way the first concentration dissolving in the 
mixture without giving any turbidity is considered the polymer solubility in the 
fraction water/acetone under investigation.  
Calorimetric data were obtained by differential scanning calorimetry (DSC) 
with a TA Instruments Q100 series equipped with a refrigerated cooling system 
(RCS) operating from -90 ºC to 550 ºC. Experiments were conducted under a flow of 
dry nitrogen with a sample weight of approximately 10 mg while calibration was 
performed with indium. Heating and cooling runs were performed at rates of 20 
ºC/min and 10 ºC/min, respectively. 
Wide angle X-ray diffraction patterns were obtained using a PANalytical 
X´Pert diffractometer, Cu Kα radiation (λ = 0.1542 nm) and a silicium monocrystal 
sample holder. 
Spherulitic morphologies were studied using a Zeiss Axioskop 40 Pol light 
polarizing microscope equipped with a Linkam temperature control system 
configured by a THMS 600 heating and freezing stage connected to a LNP 94 liquid 
nitrogen cooling system. Micrographs were taken with a Zeiss AxiosCam MRC5 
  24 
digital camera. A first-order red tint plate was employed to determine the sign of 
spherulite birefringence under crossed polarizers. 
2.3.2. Solubility 
The as-synthesized polymer is an amphiphilic polymer, with a hydrophilic 
(PEG cyanoacrylate)  and a lipophilic (hexadecyl cyanoacrylate) monomer. 
According to the results reported by Peracchia et al. (1997), the solubility of the 
polymer changes with the relative ratio between the two monomers. The ratio used 
in the synthesis here performed is one to four, meaning that the final polymer has 
one PEG monomer each four hexadecyl cyanoacrylate monomers. The as-
synthesized polymer shows a good balance between hydrophilic and lipophilic 
monomers, being soluble in most of the organic solvents. As it will become clearer 
later on, this is an advantage when the scope is to produce nanoparticles with 
solvent-displacement. 
 
Figure 2.4. Precipitation texts of the polymer at different water fraction (Kw):  polymer 
precipitates, ▲ polymer is soluble. Dashed lines indicates solubility curve. 
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Residual solubility at 30 ºC in three different water/acetone mixture has been 
evaluated. Results are shown in Figure 2.4 and numerical values of the residual 
solubility are reported in Table 2.1. The residual solubility in the mixture at 0.5 and 
0.66 is quite high and it decreases only at higher water fraction (0.9). This can be due 
to the different molecules of polymer which can be present in a batch: in fact, in the 
chemical synthesis it is not possible to control monomers distribution in a molecule, 
so that more lipophilic molecules precipitate when water amount increase, but the 
hydrophilic ones remain in solution. 
 
Table 2.1. Residual polymer solubility (g/l) in the water/acetone mixture at three different water 
fraction. 
polymer solubility 
water fraction 0.5 0.66 0.9 
g/l 0.45 0.4 0.243 
 
2.3.3. Thermal characterization 
Poly(MePEGCA-co-HDCA) has a semicrystalline character as demonstrated 
by the DSC scans shown in Figure 2.4a. Thus, the as-synthesized sample has a 
predominant peak at 53 ºC and a minor one close to 33-34 ºC, which should 
correspond to the melting of crystalline domains of PEG and the HD alkyl groups, 
respectively. The sample easily crystallized from the melt giving rise to a complex 
exothermic peak where the crystallization of the two indicated domains could not 
be well differentiated. It is interesting to note that the crystallinity of the as-
synthesized sample, which came from evaporation of a dichloromethane solution, 
could be increased by the hot crystallization process as a consequence of a better 
rearrangement of the HDCA domains.  Hence, the increase on the global melting 
enthalpy (i.e. from 123 to 138 J/g) is mainly a consequence of the peak associated to 
  26 
the melt of HDCA domains which increased and became sharper after hot 
crystallization. The DSC heating run of a quenched sample does not reveal 
significant changes and demonstrated that the sample easily crystallized even at the 
high cooling rates. Notice that the glass transition temperature could not be well 
observed due to high crystallinity of the sample. Two points are noticeable from the 
thermal analysis: a) the sample experiences a partial fusion around 34 ºC which is a 
temperature slightly lower to the human body temperature at which the potential 
drug delivery systems should be applied; b) despite the complexity of the sample, 
its crystallinity remains high indeed at the temperature of 37 ºC at which samples 
are expected to be employed.  
 
Figure 2.5. DSC scans performed on poly(MePEGCA-co-HDCA) (a), poly(HDCA) (b) and PEG 
samples (c). Scans, from bottom to top, correspond to the heating run of the as-synthesized (a,c) or 
the commercial sample (c), the cooling run from the melt state (a, b, c), the heating run of a hot 
crystallized sample (a, b, c) and the heating run of a sample quenched from the melt state (a). 
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 For the sake of completeness, in Figure 2.5b and Figure 2.5c DSC scans 
performed with Poly(hexadecylcyanoacrylate) (PHDCA) homopolymer and the 
PEG are reported. These traces clearly confirm the previous assignation given for 
the melting peaks of poly(MePEGCA-co-HDCA) and the similar crystallization 
temperature of both samples. Results also demonstrated that  poly(MePEGCA-co-
HDCA) has an intermediate melting enthalpy between those of the crystals 
constituted by the two  types of lateral chains. Basically, enthalpies associated to 
each peak (e.g. 18 and 120 J/g for the hot crystallized sample) fit reasonably well 
with the expected values (18 and 118 J/g) assuming a weight percentage of PEG 
close to 64%. Finally, it should be pointed out the complexity of the crystallization 
exothermic peak of PEG which extends over an interval of approximately 15 ºC and 
on the contrary the sharp appearance of the peak associated to the PHDCA. This, in 
addition, suggests an almost instantaneous primary crystallization that could be a 
consequence of a high nucleation density. 
2.3.4. Spherulitic morphologies 
Crystallization from the melt gave spherulites with a fibrilar texture that 
corresponded to the crystallization of the PEG lateral chains, although domains 
constituted by HDCA units could also be envisaged. Figure 2.6a shows a typical 
crystallization performed at 4 ºC (i.e. at a low degree of supercooling) where well 
developed spherulites could be observed together with zones with a different 
texture (indicated by arrows in Figure 2.6d) that seems to be constituted by smaller 
microcrystals. These zones melted when the sample was heated up to the melting 
temperature associated to the HDCA domains (Figure 2.6b) and recrystallized 
giving textures similar to those initially observed, when the temperature was 
subsequently decreased down to room temperature (Figure 2.6c). Experiments 
clearly demonstrated the complex crystallization process of samples constituted by 
blocks able to crystallize independently (i.e. those constituted by the PEG lateral 
groups and HDCA units) and furthermore with a similar crystallization 
temperature. Phase separation and crystalline morphology studies of block 
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copolymers are nowadays receiving great attention (Muthukumar et al., 1998, Zhue 
et al., 1999, Ryan et al., 1995, Schäffer et al., 2000, Kawai et al., 2007)  and even 
microstructures that can be formed from the melt, from solution and for both thin 
and bulk samples have been extensively reviewed (Müller et al., 2007, Nandan et al., 
2006).  
 
Figure 2.6. Polarizing optical micrographs of poly(MePEGCA-co-HDCA) isothermally crystallized 
at 4 ºC (a, b, c) and -24 ºC (d). Micrographs were taken at room temperature (a, d), at 34 ºC (b) and 
at room temperature after heating the crystallized sample to 34 ºC. A first-order red tint plate was 
used for micrograph d). The inset of d) shows a magnification of the dashed area where small and 
flat microcrystals could be envisaged.  Arrows points out crystalline microdomains constituted by  
poly(HDCA). 
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Nucleation density obviously increased when the crystallization temperature 
decreased and consequently smaller spherulites were observed at the end of the 
crystallization process as shown in Figure 2.6d for isothermal experiments 
performed at -24 ºC. In all cases, a negative birefringence was characteristic of the 
PEG spherulites, whereas a more confusing sign was observed for  the alkyl chain 
crystals due to their smaller size. In fact, primary nucleation was much higher for 
these crystals as suggested also by the DSC data. Optical micrographs reveal that 
the alkyl chain microcrystals had a flat appearance and usually appeared 
aggregated in such a way that the birefringence sign of the PEG spherulite was kept 
(see white and red arrows in Figure 2.6d). In some cases, these microcrystals gave 
rise to spherulite arms with a speckle appearance (white arrows). 
2.3.5. X-rays 
X-ray powder diffraction patterns (Figure 2.7) of  poly(MePEGCA-co-HDCA) 
revealed the presence of reflections characteristic of polyethylene glycol as well as 
additional peaks which should be assigned to a crystalline structure associated to 
the packing of the hexadecyl lateral groups. The structure of polyethylene glycol is 
defined by a P21/a space group and a unit cell with parameters a = 0.805 nm, b = 
1.304 nm, c (fiber axis) = 1.948 nm and β = 125.4º that contains four 7/2 helices based 
on TTG sequences (Figure 2.6c). The corresponding X-ray diffraction pattern (Figure 
2.6c) is characterized by strong peaks at 0.462 nm (120 reflection) and 0.386-0.277 nm 
(112, 032, 13-2 and 21-2 reflections) and weak peaks at 0.603 nm and 0.586 nm  
which are indexed as the 021 and 110 reflections. All of these reflections can be well 
observed in the X-ray diffraction profile of poly(MePEGCA-co-HDCA) together 
with peaks at 2.988, 1.494 and 0.416 nm of remarkable intensity. These peaks are 
also detected in the diffractogram of poly(hexadecylcyanoacrylate) and suggests a 
hexagonal unit cell with parameters   a = 0.479 nm, b = 0.479 nm, c (fiber axis) = 
2.988 nm. Thus, the stronger peak (100 reflection) corresponds to the hexagonal 
packing of the polymethylene segments whereas the higher spacing peaks can be 
indexed as the 001 and 002 reflections. Note that the c parameter is larger than the 
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expected length of a hexadecylacrylate lateral group with an extended conformation 
(i.e. ca. 1.62 nm). Hence, the c axis of the crystalline structure should correspond to 
two lateral groups as presumable if hexadecylacrylate groups in the main chain 
have a syndiotactic arrangement. Note that an isotactic arrangement should lead to 
a high steric hindrances since the spacing between polymethylene sequence should 
be close to only 0.25 nm. 
 
Figure 2.7. a) Powder X-ray diffraction profiles of poly(MePEGCA-co-HDCA) (blue) and 
poly(cyano hexadecylacrylate) (brown). b) Down the chain axis projection of the PEG structure 
showing the packing arrangement of the four 7/2 helices. c) Simulated powder X-ray diffraction 
profile of PEG and corresponding diffraction pattern (inset). 
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2.4. Degradation 
2.4.1. Measurements 
1H-NMR spectra were acquired with a Bruker AMX-300 spectrometer 
operating at 300.1 MHz. Chemical shifts were calibrated using tetramethylsilane as 
an internal standard. Dried dimethyl sulfoxide-d6 (DMSO) was used as the solvent. 
2.4.2. Degradation experiments 
Little polymer tablets were prepared by weighing 150 mg. After preparation 
every tablet was weighed by analytic balance, put in 15 ml of milliQ water and left 
at fixed temperature. Two different conditions were investigated: 4 ºC and 18 ºC. At 
scheduled time a tablet was taken out the water, well dried and weighed, in order to 
calculate the weight loss. Some of the samples were then analysed by 1H-NMR in 
order to study the polymer chemical degradation. 
2.4.3. Results 
Degradation of poly(MePEGCA-co-HDCA) in milliQ water at temperatures of 
18 and 4 ºC was characterized by a quick process that took place over a maximum 
period of 8 and 24 h and that caused a weight loss of approximately 61% (Figure 
2.8). After that, the copolymer was not sensitive to the hydrolytic attack and the 
sample weight remained practically constant, at least over an exposure time of 300 
hours (12 days).  
1H-NMR spectra were taken after different incubation times and results as 
peak areas are shown in Table 2.2. NMR spectra were performed on the dried 
polymer, except for the analysis performed at 8 hours on water medium. In this 
case, water of the degradation experiments was evaporated and the solute, 
corresponding to the fraction which was dissolved by water, was analysed at 1H-
NMR. In NMR analysis chemical shift of hydrogen is measured in respect to a 
reference (threemethyl silane) and this chemical shift is indicated as ppm, 
considering that threemethyl silane correspond to 0 ppm.  
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Figure 2.8. a) Plot of the remaining weight of a poly(MePEGCA-co-HDCA) disk sample versus 
exposure time in distilled water at 18 ºC (▲) and 4 ºC (□). b) Electron micrograph of PEG lamellar 
crystals recovered from the release medium. The inset shows the corresponding electron 
diffraction pattern. 
By comparing the area peak of different hydrogen of the molecule it is evident 
the loss in PEG chains as well in polymerization methyl (peak at 2.30-2.60). PEG 
chain loss is confirmed by the spectra performed on water medium, where PEG 
signal is very high, confirming that most of PEG remains in water.  
Table 2.2. Area of the 1H NMR peaks for each signal in the samples after degradation in water. 
pattern. 
  ppm 1.26 1.73 0.88 2.30-2.60 4.25 3.64 3.38 
homopolymer 100 7.04 11.49 5.39 7.01 -- -- 
copolymer 100 5.62 11.04 13.50 5.85 148.07 3.78 
t=8h, 18ºC 100 5.71 11.38 4.77 4.84 7.79 0.10 
t=8h, water medium, 18ºC 100 -- 8.38 183.0 -- 6801.3 144.34 
t=8h, 4ºC 100 5.95 11.44 5.78 5.75 12.33 0.33 
t=24h, 18ºC 100 5.50 11.87 4.79 6.19 3.75 0.09 
t=24h, 4ºC 100 5.61 11.75 5.76 5.78 5.96 0.21 
t=48h, 18ºC 100 4.98 11.83 4.46 4.80 5.16 0.03 
t=48h, 4ºC 100 5.36 11.92 6.29 5.94 6.81 0.21 
t=72h, 18ºC 100 5.77 11.74 4.70 5.95 4.94 0.14 
t=72h, 4ºC 100 5.71 11.08 5.40 6.22 5.27 0.15 
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Figure 2.9a and c compare the 1H-NMR spectra of the as-synthesized sample 
and that degraded up to a weight loss of 61%. The initial sample was characterized 
by a molar ratio of one to four between pegylated and hexadecyl (HD) lateral chains 
as deduced from the areas of the signals at 3.37 and 0.88 ppm assigned to the methyl 
groups belonging to the two ester moieties (Peracchia et al., 1997). Methylene 
groups of the main chain and the lateral hexadecyl and PEG groups appeared also 
well differentiated at 2.60-2.30, 1.25 and 3.64 ppm, respectively,  and consequently 
could also be considered to follow the degradation process. Spectra of samples 
exposed to water clearly shows as the signal at 3.64 ppm practically disappeared 
while the ratio between the areas of signals at 0.88 and 2.60-2.30 ppm remained 
practically constant. According to the composition determined from 1H-NMR 
spectra, the MePEG lateral groups represented a 55 wt-% of the copolymer and 
consequently the observed degradation could be well justified by the ester group 
cleavage involving only the pegylated chains.  
Spectra of the residue extracted from the hydrolytic degradation medium after 
8 hours of incubation basically corresponded, as expected, to the PEG lateral groups 
(Figure 2.9b),  although a minor amount of hexadecyl groups could also be detected 
as well as signals corresponding to the methylene groups of the main chain. In fact, 
water soluble poly(cyanocrylic acid) is produced by hydrolysis of all ester groups 
(Lenaerts et al., 1984). 
The hexadecyl groups detected in the aqueous medium were originated by 
hydrolysis of some ester groups initially accessible to the solvent which could exist 
in the solid sample and even in small polymer fractions that could be solubilized at 
the beginning of incubation. It is clear that the one to four ratio between MePEG and 
the alkyl HD lateral chains in the as-synthesized sample is an average value and 
that molecules with different compositions and solubilities must be present. Thus, a 
10 wt-% of the sample was solubilized by extraction with thrichloromethane/water 
in a period of time at which degradation was practically negligible  (i.e. less than 5% 
for 30 min of exposure) . 
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Figure 2.9. a) 1H-NMR spectra of the as-synthesized poly(MePEGCA-co-HDCA) sample and  
chemical scheme showing the assignment of signals (inset). b) 1H-NMR spectra of the solubilized 
fraction of a poly(MePEGCA-co-HDCA) sample after 8 h of exposure to water at 18 ºC. c)1H-NMR 
spectra of a poly(MePEGCA-co-HDCA) sample after 8 h of exposure to water at 18 ºC. 
The 1H-NMR spectra (see Figure 2.10) of this fraction indicated a 1:1 ratio 
between MePEG and HD lateral chains and demonstrated the existence of 
molecules with high hydrophilicity in the initial sample. 
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Figure 2.10. H-NMR spectra of polymer after extraction: polymer solubilized in water (top) and 
polymer solubilized in trichloromethane. 
In summary, 1H-NMR spectra clearly demonstrated that degradation took 
place mainly through the ester bond cleavage of the hydrophilic PEGylated chains 
whereas the cyanoacrylic backbone and even the hydrophobic hexadecyl side chains 
remained practically unaltered. It is interesting to note that the ester bond of the 
hydrophobic moiety was not highly susceptible to hydrolysis since probably it was 
not well exposed to the degradation medium. These results are in full agreement 
with preliminary studies performed on fetal calf-serum which indicates that the 
hexadecyl homopolymer was not degraded during the first 3 hours of incubation 
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whereas the studied copolymer showed a linear dependence of degradation with 
the exposure time, being attained a 30% after only 3 hours of exposure (Peracchia et 
al., 1998). However, in this case the action of esterases present in the serum medium 
could not be differentiated from a simple hydrolytic attack. It has to be also pointed 
out that the rapid loss of PEG chains can be due also to the solubilization in water of 
more hydrophilic polymer molecules. Since the synthesis does not allow to control 
monomers distribution in the polymer molecules, it can be possible that molecules 
with an higher ratio in PEG monomers dissolve in water, so that this phenomena 
cannot be distinguished from the hydrolysis of esters bonds. 
 
 37 
2.5. References 
Kawai T., Rahman N., Matsuba G., Nishida K., Kanaya T., Nakano M., 
Okamoto H., Kawada J., Usuki A., Honma N., Nakajima K., Matsuda M., 2007, 
Crystallization and melting behavior of poly(L-lactic acid). Macromolecules 40, 9463-
9469. 
Lenaerts V., Couvreur P., Christiaens-Leyh D., Joiris E., Roland M., 1984, 
Degradation of poly (isobutyl cyanoacrylate) nanoparticles. Biomaterials 5, 65-68. 
Müller, A. J., Balsamo, V., Arnal, M. L., 2007, Crystallization in block 
copolymers with more than one crystallizable block. In: Reiter G, Strobl G, editors. 
Lecture Notes in Physics: Progress in Understanding of Polymer Crystallization. Berlin: 
Springer. 
Muthukumar M., Ober C.K., Thomas E.L.,  1997, Competing interactions and 
levels of ordering in self-organizing polymeric materials. Science 277, 1225-1232. 
Nandan B., Hsu J.Y., Chen H.L., 2006, Crystallization Behavior of 
Crystalline‐Amorphous Diblock Copolymers Consisting of a Rubbery Amorphous 
Block. Polymer Review 46:143-172. 
 
Peracchia M.T., Desmaële D., Couvreur P., d’Angelo J.,  1997, Synthesis of a 
novel poly(MePEG cyanoacrylate-co-alkyl cyanoacrylate) amphiphilic copolymer 
for nanoparticle technology. Macromolecules 30, 846-851. 
Peracchia M.T., Vauthier C., Desmaële, Gulk A., Dedieu J.C., Demoy M., 
d’Angelo J., Couvreur P.,  1998, Pegylated nanoparticles from a novel 
methoxypolyethylene glycol cyanoacrylate hexadecyl cyanoacrylate amphiphilic 
copolymer. Pharmaceutical Research 15, 550-556. 
  38 
Peracchia M.T., Fattal E., Desmaële D., Besnard M., Noël J.P., Gomis J.M., 
Appel M., d’Angelo J., Couvreur P., 1999, Stealth PEGylated polycyanoacrylate 
nanoparticles for intravenous administration and splenic targetin. Journal of 
Controlled Release 60, 121-128.  
Ryan A.J., Hamley I.W., Bras W., Bates F.S., 1995, Structure development in 
semicrystalline diblock copolymers crystallizing from the ordered melt. 
Macromolecules 28, 3860-3868. 
Schäffer E., Thurn-Albrecht T., Russell T.P., Steiner U., 2000, Electrically 
induced structure formation and pattern transfer. Nature 403, 874-877. 
Zhu L, Chen Y., Zhang A., Calhoun B.H., Chun M., Quirk R.P., Cheng S.Z.D., 
Hsiao BS, Yeh F., Hashimoto T. 1999, Phase structures and morphologies 
determined by competitions among self-organization, crystallization, and 
vitrification in a disordered poly(ethylene oxide)-b-polystyrene diblock copolymer. 
Physical Reviews B 60, 10022-10031. 
 39 
3. Production of PEGylated nanocapsules through 
solvent-displacement in confined impinging jets 
mixers 
3.1. Introduction 
Polymer nanoparticles include polymeric nanospheres and polymeric 
nanocapsules. In nanospheres the drug is dispersed in the polymeric matrix, 
whereas polymeric nanocapsules have an inner liquid core surrounded by a 
polymeric layer, so that different drugs can be dissolved in the inner core, according 
to their solubility. The drug molecules inside the nanospheres are dispersed in the 
polymer matrix in a sort of solid solution, whereas in nanocapsules they are 
dissolved in the liquid core; as a consequence, drug release occurs according to 
different mechanisms in nanospheres and nanocapsules.  
This chapter is focused on polymeric nanocapsules for pharmaceutical 
applications, but also nanosphere are produced for comparison.  
Nanospheres and nanocapsules are produced by solvent-displacement (also 
called interfacial deposition or flash nanoprecipitation) which has some advantages 
respect to other preparation method (see Chapter 1). In fact, solvent-displacement 
allows to use polymers with controlled molecular weight, avoids the presence of 
residual monomers in solution, it is simpler, gives more reproducible results and it 
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is easier to scale up. Solvent-displacement consists in mixing a water miscible 
organic phase, containing the polymer, the oil and generally the drug, with an 
aqueous phase. The organic phase is referred to as solvent, whereas water is the 
anti-solvent. When the two phases are mixed together, the organic phase diffuses 
rapidly into the water, where it is soluble and where, on the contrary the polymer, 
the oil and the drug are insoluble. The rapid diffusion of the solvent in the anti-
solvent is the driving force in nanocapsule formation, inducing oily drops formation 
and the interfacial deposition of the polymer around the oily drops.  
Being the overall process very rapid it is influenced by mixing and in order to 
obtain good mixing conditions, special micro-mixers must be used. Confined 
impinging jets mixers (CIJMs) provide optimum mixing conditions. Their use in 
nanosphere formation was extensively studied (Marchisio et al., 2006, Gavi et al., 
2008, 2010) and they were found to be very useful in controlling the final particle 
size (Lince et al., 2008). CIJMs consist of two high velocity linear jets of fluid that 
collide inside a small chamber, whose size affects the overall mixing rate. 
Mixing mechanism and nanoparticle formation in CIJMs, similar to the ones 
studied in this work, were analysed in previous papers through computational fluid 
dynamics (CFD) simulations (Lince et al., 2009, Gavi et al., 2007). CFD simulations 
allow to quantify the mixing dynamics of the two inlet streams inside the mixing 
chamber. Three types of mixing are generally present: macro-mixing at the mixer 
scale, meso-mixing at the scale of the largest turbulent eddies and micro-mixing at 
the molecular scale. Each step controls the next one and can be rate limiting. CIJMs 
limit the meso-mixing time and ensure fast homogenization (i.e., short macro-
mixing time) of the two fluids. Characteristic global mixing times in these 
equipments were calculated by CFD and are in the order of magnitude of 
milliseconds (Lince et al. 2010, Lince et al., 2011a). 
The use of the CIJMs for the production of polymer nanocapsules suitable for 
pharmaceutical applications is investigated for the first time. Since the mechanisms 
of nanocapsule formation are likely different from those of nanospheres, we are 
particularly interested in investigating the interplay between mixing and 
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nanocapsules formation, with the precise scope of highlighting similarities and 
differences. Attention is played to the control of nanocapsule size distribution. In 
fact, different applications translate into different requirements. For example, in the 
case of intravenous administration, nanocapsules have to be smaller than 300 nm. 
For other applications, such as cosmetic (Alvarez-Roman et al., 2001) or food 
(Zambrano-Zaragoza et al., 2011) size limitations are different; therefore the 
development of strategies to control the final nanocapsule size turns out to be very 
useful.  
It should be highlighted that no drug loading has been considered in this 
chapter. Although in the case of nanospheres the absence or the presence of the 
drug can significantly alter the results, especially in terms of stability (as shown for 
example for doxorubicin loaded nanospheres, Lince et al., 2001b), in the case of 
nanocapsules the situation seems to be very different. In fact, the oil separates from 
the initial single-phase system through spinodal decomposition: no energetic barrier 
has to be overcome (as dictated by the Cahn–Hilliard equation) and molecular 
diffusion is the bottleneck. In addition being the drug generally hydrophobic and in 
low concentration (in comparison with the oil), drug molecules will likely move 
rapidly inside the oily drops. Indeed a successive study with a drug is required to 
prove this last point and this simpler oil-polymer system will be used as reference. 
3.2. Theoretical background 
The formation of nanocapsules and nanospheres during solvent-displacement 
is a complex process and many theories and interpretations have been presented in 
the literature. Knowledge of what happens at the molecular level is of primary 
importance for manipulating and controlling the overall process. Classical 
precipitation theory explains particle formation in three steps: nucleation, molecular 
growth and particle aggregation (Horn and Rieger, 2001). Super-saturation is the 
driving force for particle formation and in solvent-displacement is built up by 
mixing of the solvent and the anti-solvent. Since in this work we are interested in 
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both nanospheres and nanocapsules, it is necessary to review and briefly discuss the 
theory presented in the literature for these two systems. 
In the case of nanospheres, the copolymer and organic compound are 
dissolved in the solvent and when mixed with the anti-solvent particles are formed. 
Johnson and Prud’homme (2003) describe nanosphere formation as the competition 
of two simultaneous phenomena: nucleation of drug particles and copolymer self-
assembly. The two phenomena are characterized by different time-scales and in 
order to allow the copolymer molecules to interact with (and to deposit on) the 
growing particles, the two time-scales have to match one another. Typical operating 
conditions, used in the production of most of the organic-drug particles, are 
characterized by extremely high super-saturation, resulting in very small nucleus 
size, practically instantaneous nucleation, with very little energy barrier.  It is also 
important to compare these time-scales with the mixing time-scale. It was in fact 
observed that faster mixing generally results in smaller drug particles with higher 
functionalization by the copolymer, however once a certain limit is reached no 
significant change in nanoparticle properties is observed. This is probably related to 
the development of a spatially independent self-similar state caused by the 
achievement of fully turbulent flow.  
In the case of nanocapsules the inner core of the particle consists instead of a 
lipophilic liquid (usually oil) which is insoluble in the mixture of solvent and anti-
solvent. Thus in nanocapsule formation two phenomena are involved: oily drop 
formation and polymer deposition around the oily drop. Oily drop formation takes 
place through spinodal decomposition (as dictated by the Cahn-Hilliard equation). 
Therefore, although due to the high super-saturation the nucleation process 
involved in nanosphere formation generates a very small energy barrier, some 
differences between nanospheres and nanocapsules, where on the contrary spinodal 
decomposition occurs spontaneously without any energy barrier, might be 
observed.  
In addition, when solvent and anti-solvent are mixed together, the oil 
dissolved in the solvent separates resulting in drops which tend to coalesce. This 
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can be prevented by the deposition of the copolymer around the drops, however in 
the case of nanocapsules polymer reorientation on the interface might play a 
different role. In any case, also for nanocapsules mixing efficiency is expected to be 
fundamental in order to have homogeneous and optimal conditions for the 
formation of very small drops and an even distribution of copolymer molecules 
around drops.   
Some authors (Fessi et al., 1989, Quintanar-Guerrero et al., 1998) have 
acknowledged the important contribution of the Gibbs-Marangoni effect on the 
formation of nanocapsules, in which the driving force is the difference in the 
interfacial tension between the solvent and the anti-solvent. This effect is not 
considered in this work since it is important when nanocapsules are produced with 
the classical method, adding slowly the solvent to the aqueous phase. Using micro-
mixers, such as CIJMs, under very intense turbulent mixing conditions this effect is 
probably less important. 
3.3. Materials and methods 
The poly(methoxypolyethyleneglycol cyanoacrylate-co-hexadecyl 
cyanoacrylate) (poly(MePEGCA-co-HDCA) in what follows) copolymer was 
synthesized by the author as reported in Chapter 2. The ratio between MePEG 
cyanoacetate/hexadecyl cyanoacetate was one to four.  
In all experiments Miglyol® 812N was used as liquid core (courtesy of Sasol 
Italy S.p.A). This oil is a mixture of capryc and caprylic triglyceride  with a density 
of 0.94-0.95 g/cm3 . The solvent is Acetone Chromasolv (HPLC grade), purchased 
by Sigma-Aldrich. Milli-Q RG system by Millipore® was used to produce the 
ultrapure water employed in all the experiments. 
Nanocapsules and nanospheres were prepared by solvent-displacement. In 
nanocapsule precipitation the copolymer together with Miglyol was dissolved in 
acetone and then mixed with pure water, whereas in nanospheres only the 
copolymer was dissolved in the solvent. Apart from this, the two preparations were 
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identical. After mixing with water the particulate system was immediately formed. 
As already mentioned, since the process is strongly influenced by mixing, CIJMs 
were used, that ensure high turbulence levels and short mixing times. Precipitation 
was carried out with and without quenching, in order to highlight the possible 
influence of aggregation; to this purpose the outlet of the mixer (8 ml containing 
equal volumes of acetone and water) was collected in a beaker containing 4 ml of 
water. Tests have been carried out in order to identify the best quenching volume 
ratio. The 4 ml of water (corresponding to a 1:2 acetone:water final ratio in the 
mixture) was found to be a good trade off, since quenching with larger volumes did 
not results in significantly different data. 
In the laboratory set up, solvent solution and anti-solvent were loaded into 
two different plastic syringes of 100 ml of volume and fed into the mixers by using a 
syringe pump (KDS200, KD Scientific). The pump was calibrated in order to make 
sure that the imposed flow rate was actually delivered. Then, the solvent was 
removed by a rotating low pressure evaporative device (Stuart® Rotary 
Evaporators). The possible azeotrope for the acetone-water mixture is in the acetone 
rich region, therefore complete removal of acetone is possible (since the starting 
point is an already water rich solution). The effect of acetone removal on 
nanocapsules was quantified and found to be within the range of experimental 
uncertainity. Stability of the nanocapsule size after solvent removal was monitored 
by storing samples at 4°C for several weeks and measuring the nanocapsule size at 
regular time interval. No significant size changes were detected.  
Four different CIJMs were used in this work. Three of them are scaled by a 
factor of two and one has bigger inlet diameter, in order to study the effect of a 
different inlet jet in the same mixing chamber. A sketch is reported in Figure 3.1 
whereas the quotes are reported in Table 3.1. They are labelled in what follows as 
scale down, CIJM-d1, scale up (corresponding to three CIJMs exactly scaled by a 
geometric factor equal to two) and CIJM-d2 (corresponding to the same chamber 
size of CIJM-d1 but with bigger inlet pipe). The comparison of the results obtained 
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with these four mixers allows to evidence scale up and scale down effects, as well as 
the effect of the chamber and inlet pipe size on the final size distribution. 
 
Figure 3.1. Sketch of the CIJMs used in this work. 
 
Table 3.1. Geometrical details of the CIJMs used for the experiments. 
Mixer din (mm) dout (mm) Dc (mm) h (mm) Volume 
                h1 h2 h3 (mm2) 
scale down 0.5 1 2.4 0.5 4.5 0.6 22.5 
CIJM-d1 1 2 4.8 1 9 1.2 180.3 
scale up 2 4 9.8 2.3 17 3 1288.3 
CIJM-d2 2 2 4.8 1 9 1.2 180.3 
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Nanocapsules and nanospheres were characterized in terms of their size 
distribution and zeta potential. The Z-avarage size of nanocapsules was determined 
by Dynamic Light Scattering (DLS, Zetasizer Nanoseries ZS90, Malvern Instrument) 
that measures accurately in the size range from 2 nm to 3 μm. Zetasizer Nanoseries 
ZS90 does not use a movable detector, but uses classical fixed detection 
arrangement at 90° to the laser and the centre of the cell area. This arrangement 
reduces the detectable size range and requires low concentration samples. In DLS 
measurements, the intensity size distribution is converted by using the Mie theory 
to a volume size distribution. In order to obtain the volume size distribution it is 
necessary to provide the instrument the refractive index of the material (which does 
not significantly influence the final result of the measurement) and of the 
dispersant. Before measuring, the sample was diluted of 1:100 in order to reduce the 
solid concentration. In DLS it is important to have a sample with appropriate 
particle concentration, in fact, it has not to be too concentrated, because each single 
photon should be scattered only once before reaching the detector, but it has to be 
concentrated enough to result in sufficient statistics. The parameters which assure 
the quality of the measurements (i.e., poly-dispersion index, correlation function 
parameter) were controlled for each single sample and measurements were 
repeated when the quality criteria were not reached. Each sample was measured 
three times and the average value is reported in the figures.  
The surface charge of nanoparticles was inferred through zeta potential 
measurements in water, by the same instrument, after dilution 1:10. In zeta potential 
measurements the instrument measures the electrophoretic mobility, which is the 
velocity of a particle in an electric field. The zeta potential is then calculated from 
the Henry equation, that makes use of the Smoluchowsky approximation, valid for 
particles in aqueous samples. 
All the experiments were performed after dissolving the copolymer and the oil 
in the acetone. No stabilizing agent was added to the aqueous phase since the 
PEGylated polymer can act as a stabilizer due to its amphiphilic nature.  
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In order to investigate the interplay between mixing and nanocapsule 
formation experiments were carried out in a wide flow rate range up to 120 ml/min 
for both solutions. Results from previous work (Lince et al., 2011a) show that under 
these conditions the mixers work under different fluid dynamic regimes. In fact, 
microPIV measurements performed in CIJMs similar to ours (Gavi et al., 2010) 
allowed to determine the flow in the mixers: it is highly turbulent only at the 
highest flow rates (larger than 40 ml/min for the smallest mixers and larger than 90 
ml/min for the biggest) and is instead transitional for the lowest flow rates. In all 
cases however, the outlet stream is well mixed, since also at relatively low flow rates 
good mixing performances are generally obtained (Lince et al., 2011b). The reason 
for investigating the performance of these devices also at low flow rates, when the 
flow is not fully turbulent, is to verify the possibility of using mixing as an 
operating parameter to control the final nanocapsule size. The Reynolds number 
used in the figures refer to the inlet pipe and are used as label for each operating 
condition (corresponding to a particular flow rate): the turbulence we are interested 
in is the one in the mixing chamber, and as said above, we know each operating 
condition corresponds to a more or less turbulent situation in the mixing chamber. 
In these experiments the acetone solution contained 6 mg/ml of copolymer 
and 8 μl/ml of oil (7.6 mg/ml), equivalent to an oil-to-copolymer mass ratio value 
of MR = 1.26. We performed the experiments both with and without quenching to 
understand the mechanism of nanocapsule formation and the main differences with 
respect to nanospheres. In some cases experiments were repeated three times in 
order to quantify the experimental variability, reported together with the data in the 
form of error bars.  
The effect of oil concentration on nanocapsule size was studied at four 
different oil concentrations: zero (i.e. nanospheres), 4.8 μl/ml (4.56 mg/ml), 8 μl/ml 
(7.6 mg/ml) and 15 μl/ml (14.25 mg/ml) with 6 mg/ml of copolymer concentration. 
The respective oil-to-copolymer mass ratio was 0.76, 1.26 and 2.37. These 
experiments were performed in all the CIJMs. Moreover, the same experiments 
were performed in the CIJM-d1, varying the copolymer concentration (10 mg/ml, 6 
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mg/ml and 3.2 mg/ml). In this case the oil concentration was kept constant at 8 
μl/ml; in this way the oil-to-copolymer mass ratio was the same of the previous 
experiments (0.76, 1.26 and 2.37). 
A further set of experiments, keeping constant the oil-to-copolymer mass ratio, 
was also carried out. In this case both copolymer and oil concentrations were varied 
in order to check if resulted in nanocapsules with similar size. The two mass ratio 
considered were 0.76 (with the following different concentrations: 4 mg/ml 
copolymer and 3.2 μl/ml oil, 6 mg/ml copolymer and 4.8 μl/ml oil, 10 mg/ml 
copolymer and 8 μl/ml oil) and 2.37 (3.2 mg/ml copolymer and 8 μl/ml oil, 6 
mg/ml copolymer and 15 μl/ml oil) . This set of experiments was carried out only 
in CIJM-d1 mixer. 
Both the flow rate and the inlet diameter of the mixer were varied in the 
experiments resulting in different mixing regimes inside the device. Since flow rate 
(FR), velocity of the inlet jet (vj) and inlet diameter (din) are related through the 
following relationship: 
FRvd jin =4
2
π                                                                                                          (1) 
at the same flow rate, the fluid velocity is different in different mixers, 
resulting in different mixing efficiencies. According to Johnson and Prud’homme 
(2003b) the overall mixing time (τmix) when the flow is fully turbulent can be 
calculated as follows: 
2/3−∝ jmix vτ                                                                                                              (2) 
and, of course different mixers, are characterized by different residence times: 
FR
VM
res =τ                                                                                                                (3) 
where τres is the residence time and VM is the volume of the mixer. 
As determined in previous investigation by means of CFD, mixing time (τmix) 
in CIJMs like the ones here used are in the order of milliseconds, while residence 
time is always above this order of time, allowing the fluid to stay in the mixer 
enough time. 
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3.4. Results and discussion 
Nanocapsule formation was firstly investigated by comparing different mixers 
and different flow rates (with and without quenching) and subsequently by 
comparing different initial compositions (copolymer and oil concentration). Results 
for the three CIJMs geometrically similar are reported in Figure 3.2. The figure 
shows the zeta potential and the mean particle size for nanocapsules prepared with 
an acetone solution of 6 mg/ml of copolymer and 8 µl/ml of oil (resulting in MR = 
1.26) at different flow rate values, with and without quenching. 
Let us first highlight the effect of the quenching water: if nanocapsules are not 
quenched their final mean size (after solvent evaporation) is significantly larger; this 
general behavior will be observed in all the cases investigated, and will be discussed 
in the following. 
A common trend for all the mixers can be observed, and it is interesting to 
observe that it is the same for both the quenched and the non-quenched particles. 
The data seem to evidence a point after which further increases in flow rate have 
little effect; this is expected by previous works in similar fields and the theory 
explains that this should happen when the mixing time is faster than the particle 
formation time. The goal of using special intensive mixers (such as the ones used in 
this work) is to ensure that the mixing time is faster than the particle formation time 
so that the system can be mixed homogeneously, before further phenomena occur. It 
is not completely correct to specify a single break point, as in the range considered 
in fact the size is affected by fluid dynamics in a similar way, but this is true on a 
logarithmic scale. The effect of a variation of the inlet flow rate is strong at low flow 
rates (generally below 20 ml/min), while it is very weak at higher flow rates, 
generally larger than 40 ml/min. 
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Figure 3.2. Zeta potential (top) and mean particle size (bottom) versus the flow rate for 
nanocapsules obtained without quenching water (left, open symbols) and with quenching water 
(right, filled symbols) for different mixers: scale down (,), CIJM-d1 (,) and scale up (,). 
Experiments at constant polymer (6 mg(ml) and oil (8 µL/ml) concentration (MR=1.26). 
It must be said that at very low flow rate the uncertainty of the experimental 
data is relatively high, especially for the larger mixers, for which a lower 
reproducibility is observed: this may be a consequence of the fluid dynamic regime, 
as the inlet jets are laminar and thus the flow in the chamber is in the transitional 
region, with turbulence developing. In any case it seems that the size increase that is 
observed, even when no quench is used, is similar in the whole range investigated, 
included the low flow rate region, thus confirming that the mixing performances of 
these devices are good also in the laminar regime. 
In Figure 3.2 the performances of the three mixers are compared by plotting 
the size of the nanocapsules obtained versus the inlet flow rate (the flow rate in each 
of the two inlets is considered), in order to evidence the influence of the size of the 
apparatus at constant throughput. The measured zeta potential is, as average, 
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between -30 mV and -45 mV, indicating that nanocapsules are stable from the 
electrochemical point of view. They reach lower values (-40 and -50 mV) if water 
dilution is carried out. 
The scale down mixer results in the smaller nanocapsules, probably due to the 
fact that it gives the best mixing conditions, at fixed flow rate. Since scale down 
mixer inlet jet diameter is 0.5 mm, the inlet stream can reach very high velocities, 
and as a consequence, high turbulent energy dissipation rates and very short mixing 
times. But the inlet jet velocity is not the controlling variable, as shown in Figure 3.3: 
in fact, it can be noted that comparing the size obtained in the different mixers at the 
same inlet velocity, the conclusion is reversed, and the smallest nanocapsules are 
obtained in the scale up mixer, while the scale down mixer gives larger particles 
(and with higher energy costs). Only the quenched particle case is shown, but the 
behaviour is similar (at least for the three scaled mixers) for the non-quenched case. 
In these cases the ratio between the inlet jet diameter and the chamber size is 
maintained constant, thus it is not possible to evidence which one of these geometric 
parameters eventually is more important; but it may be concluded that a larger size 
is surely favourable, because it allows to increase throughput reducing at the same 
time the final particle size (or eventually to obtain the same size at reduced jet 
velocity, and thus with lower energy input). 
It is thus evident that the size of the apparatus plays a more complex role: if 
the Reynolds number is used to characterize the fluid dynamics conditions, and 
thus mixing, it is observed that the curves corresponding to the three mixers 
collapse onto a single one; of course Reynolds number can take into account only 
fluid dynamics similarity and only for geometrically similar devices, thus the 
behavior described above is observed only for the three scaled mixer and for the 
same inlet concentrations of oil and polymer (that is for a fixed characteristic 
process time). As it will be widely discussed in the next chapter, Reynolds number 
is an important parameter to scale the apparatus. It allows to consider together 
factors describing the turbulence of the system, and to find a parameter which 
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describes all the particles obtained at the same concentration in geometrically 
similar mixers. 
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Figure 3.3. Mean particle size versus the inlet stream velocity for nanocapsules obtained with 
different CIJMs: scale down mixer (), CIJM-d1 mixer (), scale up mixer (), CIJM-d2 mixer 
(). Experiments at constant polymer (6 mg(ml) and oil (8 µL/ml) concentration (MR=1.26). 
More complex to explain is the behavior of the CIJM-d2, which has the same 
chamber of the CIJM-d1, but larger inlet pipe diameters, equal to those of the scale 
up device: in particular significant differences are observed with and without 
quench. When nanocapsules are quenched, the size of the particles obtained, at a 
given flow rate, is approximately the same in the CIJM-d2 and in the scale up mixer: 
it can be noted that in this case the inlet velocity is also the same, as the pipe 
diameter is equal (see also Figure 3.3); this would suggest that the jet velocity is 
more relevant than the chamber size to determine mixing conditions. On the other 
hand, at a given jet velocity, smaller particles are obtained in the CIJM-d2 than in 
CIJM-d1: this might indicate that, for a given chamber volume, it is favourable to 
have a larger interaction zone of the two streams; it can be noted anyway that 
operating at the same jet velocity in the two considered mixers requires larger flow 
rates in the one with larger pipe diameters (the CIJM-d2), and this leads to 
proportionally shorter residence times: thus the smaller size might be also a 
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consequence of the reduced time for coalescence, and connected to a lower yield of 
the process.  
If the outlet flow is not quenched, the behavior is different: at a given flow rate 
the CIJM-d2 produces particles significantly larger than all the others, and in 
particular larger than the scale up mixer; comparing the performances at a given 
inlet velocity, CIJM-d2 and CIJM-d1 produce nanocapsules of similar size. The 
comparison with the scale up mixer evidences that in this case a larger chamber is 
favourable, as it allows to obtain smaller nanocapsules; as suggested by Johnson 
and Prud’homme (2003b), what may be relevant is the ratio between the inlet pipe 
diameter and a characteristic chamber dimension: this value must not be too large, 
to allow the mixing to be confined within the chamber. It is possible that in CIJM-d2 
the particle formation process is not completed in the mixer, and this can explain the 
significant size increase observed in case of non-quenched nanocapsules; the CFD 
simulations carried out in a previous work for the same geometry confirm that the 
mixing process (at very low flow rates) may be not complete (Lince et al., 2011a). 
This fact may be also responsible for the larger experimental uncertainty that is 
observed in the test carried out in the CIJM-d2. 
The influence on the mean nanocapsule size of the inlet pipe diameter, for 
mixers with the same chamber volume, is shown in Figure 3.4; in this case the data 
are plotted considering the inlet jet Reynolds number (for an inlet jet with average 
properties of the mixed liquid streams). It can be noted that in case of quenched 
nanocapsules a unique curve is obtained (and as discussed before, this is the same 
curve valid for all the mixers in these concentration conditions), while for non-
quenched ones larger sizes are obtained in the CIJM-d2, as discussed before. Figure 
3.4 allows also to compare the experimental uncertainty in the case of quenched and 
non-quenched processes: in the latter case it is significantly higher. Zeta potential 
measurements (not shown) result in values slightly lower than -30 mV. 
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Figure 3.4. Mean particle size versus the jet Reynolds number for nanocapsules obtained without 
quenching water (left, open symbols) and with quenching water (right, filled symbols) for CIJMs 
characterized by different inlet pipes and same mixing chamber: CIJM-d1 (,), CIJM-d2 (,). 
Experiments at constant polymer (6 mg/ml) and oil (8 µL/ml) concentration (MR=1.26). 
These results show the feasibility of CIJMs for the production of nanocapsules 
and prove that fast mixing is needed in order to control nanocapsule size and in 
order to guarantee high reproducibility. Better mixing conditions allow the 
formation of smaller oily drops and a better coverage by the copolymer, resulting in 
smaller particles. Moreover, results show that quenching is an important factor and 
cannot be avoided if nanocapsules with controlled characteristics are desired. It may 
be also concluded that the process can be scaled using the Reynolds number, at least 
for geometrically similar devices; the relative size of inlet pipes and chamber has 
shown to affect the process, but its influence on final nanocapsule size is complex, 
and cannot be taken into account with a simple relationship, such as that proposed 
for the mixing time in literature (Johnson and Prud’homme, 2003b). Also the 
influence of the mixing time will be deepen in next chapter, as well Reynolds 
number and its correlation with particle size. The effect of oil concentration on 
nanocapsule formation was also investigated. At a constant copolymer 
concentration of 6 mg/ml, the oil concentration was varied between zero (resulting 
in nanospheres) and a maximum value. Data are collected in Figure 3.5, where the 
results obtained for four different oil-to-copolymer mass ratios are reported for each 
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mixer; the data are plotted versus the Reynolds number, on the basis of the results 
discussed in the previous parts of this work, and as the experiments were carried 
out in the same flow rate range for the different mixers, obviously the extension of 
the jet Reynolds number range is different. The results confirm that for every set of 
concentrations, a single curve is obtained for the different scaled mixers (in fact, the 
approximation curve drawn in the different graphs of the figure is this common 
line), while a behaviour similar to that discussed before is observed for the CIJM-d2. 
These conclusions are generally valid also for other polymer concentrations, but as 
it will be shown in the following, for very low polymer concentrations the formation 
of nanocapsules may be difficult.  
As a general trend, it is possible to state that decreasing the oil-to-copolymer 
mass ratio the mean particle size decreases. That can be due to the fact that when 
the oil-to-copolymer mass ratio increases there is not enough copolymer to cover a 
larger surface area, resulting in bigger nanocapsules.  
Each experiment at a given oil-to-copolymer mass ratio was repeated with and 
without quenching water. Quenching reduces the final nanocapsule size, but the 
effect is stronger at higher ratios, where there is a lower amount of copolymer. As 
already mentioned, the operation of quenching allows to stop nanocapsule 
evolution and freeze them as they are immediately after exiting the CIJM. In fact, 
quenching dilutes the residual polymer concentration and the particulate system 
decreasing the probability of nanocapsule collision and further growth. If we 
compare the results at different oil-to-copolymer mass ratios, it is clear that size 
increase is larger at high MR values, where there is less copolymer to cover the oily 
drops. As a matter of fact the results obtained at MR = 0.76 present a very small 
difference with or without quenching. This suggests that the copolymer coating has 
an important role in stabilizing the suspensions and avoiding nanocapsule 
aggregation and coalescence.  
In Figure 3.5 also nanospheres produced under similar operating conditions 
are shown for comparison; the size is always much smaller than that obtained in 
nanocapsules, which is mainly determined by the size of the oil drops formed. The 
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small variation between quenched and not-quenched samples suggests that it can 
happen for further aggregation of copolymer molecules from the solution and not 
for the collision of the nanospheres. 
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Figure 3.5. Mean particle size versus the jet Reynolds number (a) and versus flow rate (b) for 
nanocapsules and nanospheres obtained at four different oil-to-copolymer mass ratios, MR = 0 
(,), MR = 0.76 (,), MR = 1.26 (,) and MR = 2.37 (,) without quenching (left, open 
symbols) and with quenching (right, filled symbols) for (from top to bottom) scale down, CIJM-
d1, scale up and CIJM-d2. Constant polymer concentration (6 mg/ml). 
In comparison to nanospheres (MR = 0), where there is no oil inside, in 
nanocapsule the energy barrier that has to be overcome due to repulsion forces in 
case of aggregation seems to be lower due to the presence of the oil. Thus the 
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stability of the nanocapsule suspension could be related with the thickness of the 
copolymer wall formed. This will surely decrease if the oil-to-copolymer mass ratio 
is increased and in the case considered is the largest at MR = 0.76. Moreover, we can 
assume that good mixing allows more copolymer to be available for covering oily 
drops. In Chapter 5 the external layers of nanocpasules will be investigated by 
means of X-Ray photo-electron spectroscopy and some conclusions which support 
this hypothesis will be discussed. 
In Figure 3.6 zeta potential is shown as a function of the size for nanocapsules 
obtained with different mixers, the flow rates and oil-to-copolymer ratios. As it is 
possible to see no significant differences are detectable depending on the mixers 
used, showing that both nanocapsules and nanospheres present the same superficial 
properties, in terms of Zeta potential, independently on the mixer used; small 
differences seem to exist between nanocapsules and nanospheres, but no significant 
differences are noted among nanocapsules obtained at different MR. The fact that 
the presence of the oil does not impact the final zeta potential value of nanocapsules 
could be interpreted as a proof of the fact that the oil stays inside the copolymer 
shell. This hypothesis is supported by preliminary experimental evidences obtained 
with XPS, shown in Chapter 5. 
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Figure 3.6. Zeta potential (mV) as a function of particle size (nm) obtained with different mixers: 
scale down (triangle), CIJM-d1 (square) and scale up (rhomb). Top graph: particles without 
quenching. Bottom graph: particles with quenching. Both nanospheres and nanocapsules are 
present: nanospheres (black), nanocapsules at MR = 0.76 (half black), nanocapsules at MR = 1.26 
(light grey) and nanocapsules at MR = 2.37 (white). 
As already reported, the copolymer concentration was also varied, keeping 
constant the oil concentration. Experiments were performed only in CIJM-d1 with 
and without quenching and all the previous trends were confirmed, as shown in 
Figure 3.7 where the data are plotted versus Reynolds as in previous cases. It may 
be noted that at low polymer concentration, the size of the nanocapsules measured 
becomes extremely large, and it is evident that the situation must be different from 
the other cases, where a proportional variation of the polymer had a relatively small 
effect. Probably under these conditions the polymer quantity available for the 
formation of the copolymer shell is too small, and the forming nanocapsules 
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collapse; in Table 3.2 particle size obtained at high mixing intensities are reported 
for each sample analysed. The sample with the lower polymer amount is oversized 
in comparison with the other samples, suggesting the polymer amount is not 
sufficient to produce nanocapsules. 
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Figure 3.7. Mean particle size versus the jet Reynolds number for nanocapsules obtained at 
constant oil concentration (8 μL/ml) and at copolymer concentration of 10 mg/ml (MR = 0.76, ,), 
6 mg/ml (MR = 1.26, ,) and 3.2 mg/ml (MR = 2.37, ,) in CIJM-d1 without quenching (right, 
open symbols) and with quenching (right, filled symbols). 
 
Table 3.2. Nanocapsule size obtained at Reynolds number ~1000 in five different samples 
corresponding to two different MR. 
oil μL/mL 8 4.8 3.2 15 8 
copolymer mg/mL 10 6 4 6 3.2 
MR 0.76 0.76 0.76 2.37 2.37 
Re ~ 1000 limiting size, 
nm 224 234 226 241 499 
 
Figure 3.8 shows results for nanocapsules obtained with CIJM-d1 for different 
initial oil and copolymer concentrations, but at the same relative mass ratio to 
investigate the role of the total concentration of both copolymer and oil. 
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The results clearly show that at MR lower than one, the total concentration of 
polymer and oil is not important, but is their mass ratio that determines the final 
size, indicating that the copolymer is able to block oily drops growth by 
surrounding them; at higher mass ratios, results depend on the polymer 
concentration. In fact, at low copolymer content much larger particles are obtained, 
even in case of quench; the relative increase observed for non-quenched particles, 
then, is very relevant. 
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Figure 3.8. Mean particle size versus the jet Reynolds number for nanocapsules obtained with 
CIJM-d1 without quenching (open symbol) and with quenching (filled symbol) at two different 
constant oil-to-copolymer mass ratio for different copolymer and oil concentrations; upper graph: 
MR = 0.76 with 4 mg/ml copolymer and 3.2 μL/ml oil (,), 6 mg/ml copolymer and 4.8 μL/ml oil 
(,), 10 mg/ml copolymer and 8 μL/ml oil (,).; lower graph: MR = 2.37 with 3.2 mg/ml 
copolymer and 8 μL/ml oil (,, – - –), 6 mg/ml copolymer and 15 μL/ml oil (,, ——). 
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As it clearly emerges, the main factor in nanocapsule formation is the relative 
amount between oil and copolymer: while the oil amount acts as a destabilizing 
factor, the copolymer amount greatly helps in preventing aggregation and 
coalescence.  
To conclude, this second data set shows that increasing the copolymer amount, 
nanocapsule size decreases and probably copolymer wall thickness increases. 
Quenching is useful in stabilizing the system, preventing further aggregation 
especially when the copolymer amount is lower (and probably the copolymer wall 
is thinner), but below a certain polymer concentration nanocapsules of controlled 
size cannot be obtained; the limit conditions, that probably depend on residual 
polymer solubility in the liquid mixture, and on process yields, require further 
investigation. 
3.5. Conclusions 
Nanocapsules were prepared for the first time using CIJMs. The results 
reported in this chapter demonstrate that CIJMs can be successfully used in 
nanocapsule production and represent possibility route for their continuous 
production. These devices provide good mixing and were already used for 
obtaining nanoparticles of different materials. The influence of mixer geometry on 
nanocapsule formation will be deepen in next Chapter. 
Different types of nanoparticles are now reaching the clinical trial level, 
therefore a continuous route for producing them with reproducible characteristics is 
highly desirable. 
Further investigations on the properties of nanoparticles produced by this way 
are shown in Chapter 5. 
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4. Production of nanospheres and nanocapsules for 
pharmaceutical use: process design and scale up 
4.1. Introduction 
This chapter is focused on the investigation of the main engineering 
parameters affecting nanocapsule size, through comparison with nanospheres. 
It has been shown that nanoparticle diameter depends on operating 
conditions, mixer characteristics and polymer concentration. Since mixing is 
important in nanoparticle formation, especially when fast process steps are 
involved, micromixers and microdevices are extensively used to precipitate 
nanoparticles, following the initial suggestion by Johnson and Prud’homme  
(2003a). Tee, Confined Impinging Jets and Vortex mixers have been tested in 
previous work for the production of both organic and inorganic particles, by means 
of reactive precipitation, solvent displacement, sol-gel process (Abkulut et al., 2009; 
Cheng et al., 2009; Gavi et al., 2008; Hussain et al., 2010; Johnson and Prud’homme 
2003a, 2003c; Lince et al. 2008, 2009, 2011a, 2011b; Liu et al. 2009; Marchisio et al., 
2006, 2008, 2009) . 
In this chapter, experimental results already shown in previous chapter are 
studied and compared with results from previous work, in order to understand 
which parameters affect more significantly final nanocapsule size in CIJMs. Fluid 
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dynamics plays an important role and the flow field and mixing dynamics have 
been deeply investigated, both experimentally (Johnson and Prud’homme, 2003b, 
Gavi et al., 2010) and through Computational Fluid Dynamics (CFD) simulations 
(Cheng and Fox 2010, Lince et al. 2009, 2011a, 2011b; Icardi et al., 2011; Gavi et al., 
2007, 2010; Liu and Fox, 2009), confirming that both the inlet jet diameter and the 
mixer chamber size can influence the final particle size.  
Studying in details poly-ε-caprolactone (PCL) nanoparticle production by 
flash-precipitation, design criteria applicable to polymeric nanosphere production 
have been defined, showing also that the complex interaction between mixing and 
polymer concentration can be taken into account by means of the Damkhöler 
number, defined as the ratio between the characteristic mixing time and the particle 
formation time (Lince et al., 2011a). 
It has been suggested that scale up criteria in CIJMs can be based on the 
mixing time for both inorganic and polymeric particles and also for homogeneous 
competitive reactions. In a previous work mixing times in CIJ and Tee mixers of 
different size have been calculated by CFD (Lince et al. 2011a). A different approach 
was used by Johnson and Prud’homme (2003b) who studied these mixers using 
competitive fast reactions as a probe: the dependence of the mixing time on the 
operating conditions is derived from turbulent mixing theory and is correlated to 
characteristic geometric parameters, such as the dimensionless inter-nozzle 
separation (Δ=Dc/dj, where Dc is the chamber diameter and dj is the inlet jet 
diameter). 
The Damkhöler number, that comprises both mixing time and the 
characteristic particle formation time, function of the polymer concentration, gave 
encouraging results, allowing in particular the deep investigation to describe the 
performance of different devices, like Tee-mixer and CIJMs (Lince et al., 2009, 
2011a). The scatter of the experimental data partially masked the eventual 
differences between mixers of different size and geometry, evidencing anyway a 
band where the size of produced nanospheres with different devices was confined; 
this was already a result of relevant practical interest. A deeper analysis of the data 
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highlights a stratification of the data obtained in different mixers, similarly to what 
can be observed also in the selectivity data for homogeneous competitive mixing-
sensitive reactions published by Johnson and Prud’homme (2003b) in CIJMs of 
different size and with different Δ value. This suggests that the Damköhler number 
takes into account some of the phenomena, but does not describe all those occurring 
in the mixers. It must be also noted that generally the value of Damköhler number 
cannot be easily calculated for a system, and thus its use is of limited practical 
interest for evaluating a new device or a different polymer or reaction, even if it has 
been proved effective for correlating experimental data. In fact, it requires to know 
the kinetics of the process of interest, or at least its order; kinetic information are 
available for a limited number of inorganic precipitation (see Marchisio et al., 2006 
for an example), but very rarely these data are known for processes occurring in the 
precipitation of polymeric particles by solvent-displacement. In addition, it requires 
the knowledge of the mixing time, that in turns depends on the geometry of the 
mixer and on the fluid properties. As already mentioned, in Lince et al. (2011a) CFD 
is used to calculate it, whereas in Johnson and Prud’homme (2003b) it is related to a 
constant which depends on the geometry. It can be evidenced that the previous 
authors always refer to the micromixing time (therefore assuming that this is the 
controlling phenomenon) whereas Liu and Fox (2006) propose to use the sum of 
micro, meso- and macro-mixing time. 
The use of the Reynolds number, that allows to take into consideration size 
and hydrodynamics of the device has also been considered in some cases (Marchisio 
et al., 2006; Lince et al., 2011a), but no extensive investigation of its relevance for the 
production of polymeric nanoparticles has been carried out up to now. 
In this chapter the size of particles obtained with different micromixers will be 
related to the operating conditions, and in particular to the polymer and oil initial 
concentration, and to the hydrodynamics conditions in the mixer, in order to find 
how they affect nanoparticle precipitation. Previous experiments (see Chapter 3) 
will be also compared with experiments carried out at non-equal solvent and anti-
solvent flow rates. CIJMs are investigated in this chapter, focusing on the influence 
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of the scale, for apparatus with the same geometry and on the complex role of the 
relative size of the inlet jets with respect to the chamber diameter. The phenomena 
of the CIJMs will be also compared with that of other mixer geometries, in 
particular the Tee-mixer (TM) and Multi-inlet Vortex Mixer (MIVM), to evidence the 
influence of the mixing chamber and of the impinging jets. Finally, the relevance of 
the different dimensionless number of interest in this case will be evaluated, in 
order to suggest a scale up criterion that allows at least a partial similitude for this 
very complex process. 
4.2. Materials and methods 
4.2.1. Materials 
Nanocapsule data which are used in this chapter are the same shown in 
previous chapter. Nanosphere data come from previous work already published 
(Lince et al., 2011a) and are all quenched. Nanocapsules measurements were 
performed after solvent evaporation, while nanosphere data were obtained from 
samples not evaporated. 
Nanospheres obtained in MIVM were produced from an acetone solution of 6 
mg/ml of copolymer poly(MePEGCA-co-HDCA) with the same procedure 
described in previous chapter and samples were analysed after solvent evaporation 
through Dynamic Light Scattering (DLS) with Zetasizer Nanoseries ZS (Malvern). 
4.2.2. Mixers 
CIJMs with scaled dimensions and different geometrical details were used. 
Four different mixers with conical heads were used, three scaled with the same 
geometry and one with larger inlet jets diameter. In the three scaled mixers Δ=Dc/dj 
is 4.8 whereas in CIJM-d2 is 2.4. For comparison purposes Tee-mixer of two 
different size were used in producing nanospheres. Preliminary texts for the 
production of nanospheres and nanocapsules on vortex mixer were performed and 
results are here shown and compared with the performance of CIJMs. Two 
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geometries of MIVMs were texted: one with two inlet jet (VM-2) and another one 
with four inlet jets (VM-4).  Geometrical detailed are shown in Figure 4.1 and 
numerical details are given in Table 4.1.  
 
 
Figure 4.1. Confined Impinging Jets, Tee and Vortex Mixers: section view. 
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Table 4.1. CIJMs, Tee and Vortex Mixer numerical details. din is the inlet diameter, dout is the 
outlet diameter, Dc is the chamber diameter. 
 
Flow rates in the range between 3 and 120 ml/min were investigated, usually 
with an equal flow rate of solvent and anti-solvent. A series of experiments with the 
water/acetone ratio (W/A) varying between 1 and 8 (obtained by reducing the 
acetone flow rate at constant water flow) were also considered. 
4.2.3. Nanoparticle preparation 
Nanospheres and nanocapsules were prepared through the solvent-
displacement technique as described in previous chapter. Let me remind the way of 
preparation and some terms which will be used in this chapter.  
The poly(MePEGCA-co-HDCA) was dissolved in acetone (solvent) together 
with the oil (in the case of nanocapsules) and the acetone solution was mixed with 
water (the antisolvent). The product was collected in an empty beaker (without 
quenching) or in a volume of 4 ml of water (with quenching). Nanoparticles were 
prepared at different oil to copolymer mass ratios, MR, corresponding to the 
following values: MR = 0 (nanospheres) and MR = 0.76, 1.26 and 2.37 
(nanocapsules). These ratios are calculated using the mass in grams of the oil and of 
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the copolymer, whereas throughout the paper the oil concentration in the acetone 
solution is generally given µl/ml. The initial copolymer concentration in the solvent 
ranged from 0.7 mg/ml to 15 mg/ml. In nanocapsule production the MRs were 
obtained varying the copolymer from 4 mg/ml to 10 mg/ml and oil concentration 
from 3.2 µl/ml to 10 µl/ml.   Flow rate in the range between 3 and 120 ml/min was 
used, usually with an equal flow rate between solvent and anti-solvent. A series of 
experiments were carried out varying the water/acetone ratio (W/A) between 1 
and 8, reducing the acetone flow rate. 
Quenching allows to dilute the mixture out of the mixer, avoiding possible 
further aggregation phenomena. Some experiments were carried out without 
quenching in order to see and eventually determine an effect of quenching. 
4.3. Results and discussion 
4.3.1. Nanospheres (MR=0) in CIJMs 
Figure 4.2 shows an example of the dependence of the final mean particle size 
on the flow rate (FR) for nanospheres obtained in CIJMs at different W/A ratios. 
The mean particle size here reported is the Z-avarage size obtained by DLS.  As it is 
seen increasing the flow rate the mean particle size decreases. The effect of flow rate 
on polymeric nanospheres was extensively investigated and discussed in previous 
works (Lince et al. 2008, 2011b); further analysis of available unpublished data 
confirms that the trend is the same at every concentration and with every mixer. In 
fact, at higher flow rates the solvent and the antisolvent mix faster resulting in 
higher supersaturation levels and thus in smaller particles. Figure 4.2 also shows 
that, as it was already noted in previous works, at least at lower polymer 
concentration, for a given flow rate, when the antisolvent-to-solvent ratio is 
increased, the particle size increases, probably as a consequence of the lower mixing 
efficiency achieved; in fact, it must be reminded that W/A increases because the 
acetone solution feed is decreased, and thus also the turbulence intensity in the 
chamber is reduced.   The feed flow rate influences not only the turbulence level in 
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the mixer (which is affected by the inlet jet velocity and thus by the inlet jet 
diameter) but also the residence time (which in turn is affected by the mixer 
volume). As it will be cleared out in the next section, the residence time has a minor 
role in the investigated conditions, with respect to turbulent mixing, thus data will 
be analysed comparing the performances at equal inlet velocity in order to have 
comparable turbulent conditions. 
 
Figure 4.2. Nanosphere size dependence on solvent feed flow rate with CIJM-d1 at two different 
W/A ratios:  W/A = 1,  W/A = 8. Inlet copolymer concentration: 2.5 mg/ml Quenched, measured 
after synthesis. 
The influence of the inlet jet velocity is shown in Figure 4.3 at different 
copolymer initial concentrations: the mean size of nanospheres obtained by CIJM-d1 
is compared with the average of those obtained by TM-d1; in this case the jet 
velocity is varied by modifying the flow rate, while the inlet diameter is kept 
constant (1 mm) for both the mixer geometries compared in the figure. 
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Figure 4.3. Nanosphere size depenedence on average inlet jet velocity in CIJM-d1 and TM-d1 
mixers at different initial copolymer concentrations.  (a) CIJM-d1: 0.7 mg/ml (), 2.5 mg/ml (), 
4.0 mg/ml (), 6 mg/ml (), 10.2 mg/ml (); (b) T-d1: 4.0 mg/ml (), 6 mg/ml (), 10 mg/ml (), 15 
mg/ml (). Quenched, measured after synthesis. 
The relationship between the mean nanosphere size (dp), the inlet jet velocity 
and the initial copolymer concentration (Cpol) seems to be well represented by the 
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following empirical equation for both geometries (see also Figure 4.4 that shows the 
dependence of the proportionally terms Avj=dp/vj0.2, where dp is in nm and vj is in 
m/s): 
dp = A0 (Cpol)0.2 (vj)-0.2                                                                                                   (1) 
where the parameter A0 takes the value 101.3 and 109.2 for CIJM-d1 and TM-d1 
respectively. As it can be seen CIJM-d1 results to be a little bit more efficient than 
TM-d1 allowing the production of smaller nanoparticles, thanks to the mixing 
chamber which allows better mixing, as extensively discussed in Lince et al. (2011a). 
 
Figure 4.4. Dependence of nanosphere size on copolymer concentration in two different mixers: 
CIJM-d1 (, continuous line) and TM-d1 (, dashed line). Quenched, measured after synthesis. 
The proportionality constant of the relationship dp = Avj vj-0.2 is plotted, calculated from the data 
shown in Figure 4.3. 
The effect of the antisolvent-to-solvent ratio, W/A, on mean nanosphere size is 
reported in Figure 4.5 at FR = 120 ml/min. As already shown in Figure 4.2, 
modifying the relative flow rate of solvent and antisolvent, that is the W/A ratio, 
affects the particle size, but the trend with respect to the antisolvent (water) flow 
rate remains the same. It is shown that while at low polymer concentration the 
particle size increases slightly with W/A, at higher concentration the trend is 
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reversed. The different behaviour in the two cases can be due to the fact that at high 
polymer  concentration, the attainement of supersaturation conditions is favoured 
by increasing the relative amount of water, as solvent dilution becomes faster, even 
if mixing is less effective. At low concentration, when the copolymer is already 
diluted in the initial solvent solution, the negative effect of increasing the mixing 
time predominates, reducing nucleation rate and thus causing the particle size to 
increase as will be discussed in the next section. CFD simulations clearly indicate 
the reduced mixing efficiency when the W/A ratio increases (Lince et al. 2011b). 
Thus the dependence of nanoparticle size on the investigated parameters can be 
described by the following general relationship 
dp = Fpf A0(W/A)γvjβCpolα                                                                                              (2)                                                                                                                                             
α and β have already been estimated (see equation 1): α= 0.2 and β=-0.2. A0 
depends on the mixer used and it can be considered as the size obtained at vj = 1 
m/s, W/A = 1 at a polymer concentration of 1 mg/ml. In the previous cases 
nanoparticle size has been measured just after synthesis, quenching them to avoid 
further growth; the final particle size is affected by treatment after synthesis, for 
example by solvent evaporation, especially if not-quenching is used.  
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Figure 4.5. Dependence of mean nanosphere size (a), estimated number of particle formed  per 
millilitre of solvent fed (b) and Zeta potential (c) on W/A ratio at two different initial copolymer 
concentrations: 2.5 mg/ml (), 10.45 mg/ml ().Water flow rate = 120 ml/min. Quenched, 
measured after synthesis. 
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The factor Fpf allows to take into account the effects of post-formation 
treatments on nanoparticle size, which, as said before, usually bring to an increase 
in particle size. 
Fpf = fq*fse 
where Fpf is the post formation size factor, fq is the no quenching factor and fse is the 
solvent evaporation size factor. 
Increasing the W/A ratio forces the impinging plane to move from the central 
zone of the mixer, finally leading to lower mixing efficiency. In CIJMs geometries it 
is important the two fluids have similar momentum in order to avoid that a fraction 
of fluid leaves the chamber unmixed. Even with equal flow rate the mixing plane 
moves from the mid plane because the two fluids have different density. This fact 
has a limited effect; on the contrary, different flow rate causes a strong variation, as 
shown by previous CFD investigation, and the effect is related to the property of the 
solvent.  
Vortex mixers can overcome CIJM limitations. In these mixers the inlet jets are 
tangential to a cylindrical chamber: each stream contributes to lead to micromixing 
in the chamber and so it is possible to operate with an inlet at higher flow rate and 
another one at lower flow rate. Some preliminary results on this mixers will be 
presented in chapter 4.3.5. 
Comparing the results obtained in this work on the copolymer and previous 
ones on the PCL nanospheres (Lince 2010, Thesis), it can be observed that in this 
case the influence of the W/A ratio on final size is stronger, while the effect of the 
initial concentration is weaker. In principle, this will allow to improve the efficiency 
of the process, operating at higher concentration, but keeping small the particle size 
modifying the W/A ratio; for this reason, a modification of the mixing geometry that 
reduces the penalization caused by higher W/A ratio would be particularly 
advantageous. 
Nanosphere size depends on competing nucleation and growth phenomena: 
generally an improvement of the mixing efficiency leads to smaller final particles 
because increases the number of particles that can grow only to a limited extent. In 
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order to better understand the role of the polymer initial concentration, it is 
necessary to separate the contributions of the two mechanism: this is difficult, but 
some indications can be obtained with the help of some simplifying assumptions. 
The factors determining final particle size are three: number of formed nuclei, 
available polymer amount and yield. The number of nuclei depends on nucleation 
velocity, i.e. on supersaturation which is a function of initial concentration and 
mixing and of the interaction volume where the nucleation takes place, which in 
turns depends on mixer geometry (the inlet jet relative size can have a role) and 
hydrodynamics. The total amount of polymer available for growth depends on 
initial concentration, volume of solvent and antisolvent and solubility limits. Yield, 
related to the residual supersaturation in the outlet solution, depends on residence 
time and growth rate (which can be eventually limited by mass transport). The 
relationship between particle size and described variables is thus the following 
dp3 = 8η/π*[cpol VA – cpol,eq (VA + VW)]/(ρpol NP)                                                   (3)                                                                                                    
where dp is the particle diameter, η is the yield, cpol is the copolymer inlet 
concentration, cpol,eq is the equilibrium copolymer concentration in the water-acetone 
mixture, VA and VW are respectively the acetone and the water volume considered, 
ρpol is the copolymer density and NP is the number of particles formed. 
If the number of particles formed was not influenced by the concentration, this 
variable would affect only growth, and for unity yield a dependence of size on cpol1/3 
would be expected. The significantly lower experimental value clearly indicates that 
nucleation is affected by polymer concentration.  
From equation 3 an estimation of the concentration of nuclei formed can be 
obtained. Yield is assumed to be one and residual solubility to be negligible for sake 
of simplicity, even though it is not so low, as shown in Chapter 2; of course these 
values must be regarded just as an indicative number, because are dependent on the 
assumptions done.  
Figure 4.5b shows the influence of the W/A on the estimated nuclei 
concentration, confirming that at higher concentration the reduction of size is 
related to the increase in nucleation rate; the opposite occurs for the lower 
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concentrations. It can be noted that at value W/A=1, the nuclei concentration 
increases with initial polymer concentration. It is also possible to extract a 
relationship (at W/A=1) for the dependence of nuclei concentration on jet velocity 
and polymer concentration. From equation (3) 
3
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pol
A d
c
V
NP
∝                                                                                                                      (4) 
Plotting data at different initial polymer concentration, as a function of flow rate the 
dependence on vj can be estimated: since the slope does not change with the 
polymer concentration, it can be calculated the dependence from cpol by plotting the 
intercepts. The following relationship is found: 
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This dependence is stronger than that observed for PCL, suggesting that the 
formation of nuclei is slower for the copolymer investigated in this work, thus 
limiting more severely the rate: an increase of the concentration has therefore a 
more sensible effect. 
4.3.2. Nanocapsules in CIJMs 
In the first set of experiments nanocapsules were prepared using three scaled 
CIJMs (Δ = 4.8) and one at Δ = 2.4 at a fixed copolymer and oil concentration 
(oil/polymer mass ratio MR=1.26 with a copolymer concentration of 6 mg/ml), to 
investigate the effect of the concentration. Results, as function of the jet velocity for 
the different mixers, are shown in Figure 4.6. Only quenched particle are taken into 
consideration in this first step, to highlight the influence of operating parameters. 
Let us remember that operating with quenching means that the mixture reaction is 
collected and diluted in water. With quenching nanocapsules are a little smaller and 
the difference between quench/no quench is influenced even by mixer geometry: 
the effect is complex, function also of the oil and polymer concentration, and related 
to more complex phenomena that requires further investigation, as discussed in 
Chapter 3. In all the cases shown for nanocapsules the size has been measured after 
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solvent evaporation. The data show that in this case the dependence on the inlet 
velocity is the same in the four different mixers, and (at least for quenched particles) 
also for the different MR values investigated: α=-0.14. 
Figure 4.6. Dependence of nanocapsule size on average inlet jet velocity vj at three different oil to 
polymer concentration ratio, MR: inlet copolymer concentration = 6 mg/ml, oil concentration 
variable. Quenched, measured after solvent evaporation. Mixers: scale down (), CIJM-d1 (), 
scale up () and CIJM-d2 (). 
The graphics show a clear dependence of particle size on mixer size for all the 
cases. In particular it can be noted that the performance of CIJM-scale up and CIJM-
d2, which have the same inlet jet diameter (and thus the same velocity), have similar 
performances, independently on the chamber size. Much strong is the effect of MR 
on final particle size, as shown clearly in Figure 4.6. This strong effect has been 
confirmed also by experiments carried out varying the oil concentration.  
These results confirm that, as discussed in Chapter 3, the main parameter to 
take into account is probably the ratio between the quantity of oil and the quantity 
of copolymer. It affects the final particle size and slightly also the Zeta potential, as 
it will be discuss later. As discussed in previous chapter, nanocapsule formation is a 
more complex process than nanosphere synthesis, because it involves the oily drop 
formation and the deposition of the polymer wall that should block coalescence 
phenomena. Polymer works as a stabilizer of the oily drop, and it is necessary that 
its amount in the solution is sufficient to cover all the oily drops.  
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4.3.3. Characterization 
Zeta Potential 
Nanospheres and nanocapsules precipitated from an initial copolymer 
solution of 6 mg/mL were characterized both in term of size and Zeta potential (as 
shown in previous chapter). The aim is to compare nanocapsule data (the same of 
previous chapter) and nanosphere data from previous work. Particles are 
considered stable if the Zeta potential is in the range between +30 mV and -30 mV: 
as shown in Figure 4.7 the Zeta potential is in the range -20 mV and -50 mV, but 
generally below -30 mV. Dashed curves on the graph group together particles at the 
same MR: as discussed in previous chapter the data show that there is no strong 
relation between either Zeta potential and size, or between Zeta potential and 
composition; it must also be evidenced that the scatter of the data is relatively large, 
even within the same set of experimental results. Figure 4.7 shows the correlation 
between Zeta potential and particle size for quenched nanospheres and 
nanocapsules (upper graph) and a comparison between quenched and not-
quenched nanospheres and nanocapsules (lower graph, please note that the x-axis 
scale is larger than before). It can be noted a slight dependence of Zeta potential on 
particle size, with Zeta potential values closer to zero when particle size is smaller. 
In Figure 4.5c it is shown the effect of W/A ratio on Zeta potential in 
nanospheres, which become bigger and less stable increasing the W/A ratio: it can 
be noted that more concentrated samples give nanospheres with lower Zeta 
potential. It can be due to the fact that in smaller nanospheres PEG chains are in the 
external layers, as it is expected, while increasing nanosphere size some PEG chains 
can be trapped inside the particle, therefore modifying the surface characteristics of 
the particle itself.   
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Figure 4.7. Zeta Potential – particle size relationship; data refer to nanocapsule and nanospheres 
produced in the four CIJ mixers at 4 different FR (5, 40, 80 and 120 ml/min), measured after solvent 
evaporation. Upper graph: influence of the MR for quenched nanoparticles;  for MR 0 
(nanospheres),  for MR 0.76,  for MR 1.26 and  for MR 2.37. Lower graph: comparison of 
quenched and non-quenched nanoparticles. 
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Solvent evaporation and quenching effect 
Solvent evaporation and quenching are two processes which were investigated 
in order to highlight their effect on final particle size. Solvent evaporation is a step 
required by pharmaceutical application, whereas quenching is a procedure which 
can help to stabilize the system.  
 
Figure 4.8. Dependence of nanospheres and nanocapsules on mixer dimension. Graph a) 
Nanospheres at 6 mg/ml for different mixers: line (─) approximation of CIJM-d1 data, line (-∙∙-) 
approximation of CIJM-d2 data, line (---) approximation of CIJM-d1 data without solvent-
evaporation, line (---) approximation of CIJM-d2 data without solvent-evaporation. Graph b) 
Nanospheres at 6 mg/ml for different mixers without quenching:  line (─) approximation of CIJM-
d1 data, line (∙∙∙∙) approximation of CIJM-d2 data. Graph c) Nanocapsules at MR 1.26 with 
quenching for different mixers. Graph d) Nanocapsules at MR 1.26 without quenching for 
different mixers. 
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In Figure 4.8 both nanosphere and nanocapsule results are shown, comparing 
the results obtained with and without quenching. In graph a) it is also possible to 
see the effect of evaporation: dashed lines relates to particle size without any 
evaporation steps (data are not shown for sake of clarity). Nanospheres are slightly 
larger after solvent evaporation. The Fpf described in the nanosphere section is about 
1.1. The effect of evaporation in nanocapsules seems to be negligible, as shown in 
Figure 4.9, where the variation between pre and post evaporation is practically 
absent. 
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Figure 4.9. Nanoacapsule size at different flow rate, before (circle symbols) and after (square 
symbols) solvent evaporation. Open symbols are for not-quenched samples and filled symbols for 
quenched samples. 
Graph 4.8b) shows the results of nanospheres obtained without quenching. 
The two lines show the effect of the Δ parameter on the size. Dashed line refers to 
CIJM-d2 data, continuous line to CIJM-d1 data. On graph c) and d) data referred to 
nanocapsules are shown (c) graph with quenching, (d) graph without quenching, in 
the case of MR=1.26. It can be noted that the slope of nanospheres and nanocapsules 
are different, indicating a different role of hydrodynamics, probably related to the 
different formation-controlling mechanism. Nanocapsule formation is a more 
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complex phenomena than nanospheres precipitation and results show that 
dependence on fluidodynamic is less strong than in nanospheres. Nanocapsules are 
a system with two components and their formation depends on the oily drop 
formation and on polymer deposition, whereas in nanospheres there is just one 
component and nucleation and growth steps are the two phenomena involved in 
their synthesis. 
4.3.4. Relationships for particle size and scale up 
As discussed in the introduction, the Damkhöler number (Da) has been 
proposed to correlate the size of polymeric nanoparticles obtained by 
nanoprecipitation. It has been successfully employed also for inorganic reactive 
precipitation and complex homogeneous reactions. Using the Damkhöler number 
allows to take into account mixing efficiency and process kinetics, even if it is 
necessary to previously evaluate the mixing time in the considered apparatus and 
have sufficient information on the kinetic order of the process involved.  
As a first attempt the data concerning the nanospheres (obtained at different 
initial concentration in different mixers) have been correlated using the Damkhöler 
number, to verify the validity of this approach and the possibility to use Da as a 
scale up criterion. For this purpose Damkhöler number has been defined as 
'ατ polpmix ckDa =         (6)                                                                                                                           
assuming an α’ kinetic order for the process controlling the particle formation, 
presumably the nucleation step; τmix, the mixing time, evaluated as the sum of 
micro, meso and macromixing time as suggested by Liu and Fox (2006), has been 
calculated by CFD as discussed in previous work (Lince et al., 2011a).  
Unfortunately the value of the kp constant is not available, but this is not a big 
problem if the purpose is to correlate data concerning the same polymer, as its value 
is incorporated in the proportionality constant. In order to keep the quantity 
dimensionless, the concentration has been divided by a reference concentration, 
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taken as unit in the same units used for the polymer concentration. Thus in the 
upper graph of Figure 4.10 
)/( ,refpolpolmix ccDa τ=                                                                                                 (7) 
 
 
Figure 4.10. Correlation of experimental data using mixing time and Damkholer number in 
different mixers. Upper graphh: nanospheres, quenched, measured after synthesis, copolymer 
concentration in the range 2.5 -15 mg/ml (only 10 mg/ml for the scaled up mixers), flow rate in the 
range 20-120 ml/min. Lower graph: nanocapsules, quenched, measured after solvent evaporation, 
flow rate in the range 20-120 ml/min; all data at the same concentration: copolymer = 6 mg/ml, oil 
= 8 mg/ml. 
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The value of α’ has been chosen as the one that gives the best correlation for 
the data obtained in a single mixer: it resulted to be about 0.9 for both CIJM-d1 and 
TM-d1. The initial concentration tested ranged from 2.50 to 10 mg/ml for CIJM-d1 
and from 4 to 15 mg/ml for TM-d1. It can be noted that the quality of the correlation 
is quite good for both mixer and their performances are also very similar. This is just 
a consequence of the fact that at the same flow rate the two mixers have similar 
mixing time, and, as already shown in Figure 4.4, the sizes of the particles produced 
by them are close. 
Further analysis of the data show that dp∝Da0.22 for all mixers; considering that 
Da∝cpol0.9, the same value dp∝cpol0.20 obtained by the investigation of the dependence 
on polymer concentration is recovered. 
On the other hand it is evident that correlation vs Da is dependent on the size 
of the mixer, as it is not possible to get the different curves to collapse on a single 
curve even in case of perfectly geometrically similar mixers. On the same figure 
data referring to the scale up CIJM and Tee-mixer show what said above. For CIJM 
scale up and Tee-mixer scale up only data at 10 mg/ml are available and this 
explains the lower range shown. 
In case of nanocapsules there is a further difficulty in using Da to correlate the 
data, because it is not clear which is its kinetic expression. Limits of this approach 
are shown plotting the data versus the mixing time; data set is at the same 
copolymer and oil concentration, thus data are comparable and conclusions are 
valid. In this case three CIJMs are compared, differing for the size or for the relative 
dimensions of the inlets. Figure 4.10 (lower graph) shows that three different curves 
are obtained for the three mixers (also the slope is different in this case). Thus it is 
confirmed that Damkhöler accounts for interaction of hydrodynamics and fast 
process kinetics, but it is not useful for scale up, and mixing time itself does not 
allow to account for small differences in the geometry of the mixers. 
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Figure 4.11. Dependence of nanocapsule average diameter on CIJ mixer geometry (chamber to 
inlet jet diameter ratio); inlet copolymer concentration = 6 mg/ml, MR = 1.26, Dc/dj = 4.8 (open 
symbols) and Dc/dj = 2.4 (filled symbols) are compared. Circles are for quenched samples and 
triangles are for non-quenched samples; measured after solvent evaporation. 
It can be noted that in the range of operating conditions considered the mixing 
time, evaluated from CFD simulations, shows a weaker dependence on jet velocity 
than the one predicted by the correlation proposed by Johnson and Prud’homme. 
(2003b), who took into account micromixing time. In this case micromixing time 
gives a smaller contribution to the total mixing time, which in turns shows a 
dependence on jet velocity close to -1 or slightly higher (but always lower than -
3/2); it can be noted that in our case two liquids with different properties are mixed 
while Johnson and Prud’homme considered aqueous solutions. In any case the 
conclusions do not change even considering only the micromixing time. 
In order to highlight the potentially relevant dimensionless number a 
dimensional analysis has been carried out. It is clear that as the formation of 
nanoparticles is very complex, with different mechanisms potentially contributing, 
it may be necessary to take into account several of them. 
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In nanosphere formation, two are the main steps involved: nucleation and 
growth. After nucleation, which depends mainly on the mixing efficiency, growth 
step depends on the residual supersaturation, on transport resistences and on 
residence time. In nanocapsule formation there is firstly the oily drop formation, 
followed by the polymer deposition around it, with eventually successive breakage 
or coalescence and wall growth.  
It is also well known that in reactive systems, or in systems where complex 
particle formation mechanism occurs, as in this case, a perfect similitude of 
geometrical, hydrodynamic and kinetic factors is never possible. For reliable scale 
up, based on what is defined approximate similitude or partial modeling, it is 
important to find out which are the most important dimensionless numbers. This is 
just the aim of this work. 
In dimensional analysis plays a fundamental role the choice of the variables 
which are considered influent in the overall process.  
For the nanospheres it can be assumed that 
dp ∝ K dja vjb Dcc ρd µe kpf cpolg kGh τmixk                                                             (8)                                                                                                         
thus considering relevant the geometric size of inlet jets, dj, and chamber diameter 
(as parameter which takes into account the volume of the mixing chamber), Dc, 
average fluid density, ρ, and viscosity, µ, the polymer inlet concentration, cpol, and 
the kinetic constant relative to particle formation  (nucleation), kp and particle 
growth, kG. The final conclusion does not change if a fractional kinetic order is 
considered, as before, that is rnucl=kpcpolα’, but this adds a parameter that must be 
known. In addition also a quantity related to the turbulent energy dissipation in the 
mixer is included; this is essential to take into account the micromixing time. The 
average energy input could have been considered, for example including the 
pressure drop in the mixer, but for simplicity the mixing time has been taken into 
account (alternatively the eddy-break up time, proportional to kt/ε was a good 
choice). 
The dimensionless numbers that come out are the geometric parameter 
Δ=Dc/dj, the Reynolds number (ρvjdj)/µ (or alternatively Rec based on Dc), the 
  90 
Damkhöler number based on nucleation characteristic time (τmix kp cpolα’), the ratio 
of the characteristic time of nucleation and growth, and the group (kG cpol)/vj that 
can be considered a second Damkhöler number based on growth time and residence 
time (which is inversely proportional to the inlet velocity). 
For the nanocapsules also the oil concentration must be considered; this leads 
to an additional dimensionless number, that is the ratio of the characteristic time of 
oil drop formation and polymer film formation. In case the kinetic order of two 
processes is the same, it reduces to concentration ratio (or MR, already discussed). 
A similitude analysis leads to the same conclusions.  
It has already been shown that for nanospheres the final size depends on vj and 
initial polymer concentration. In the following, results shown in Figure 4.8 and 
Figure 4.11 will confirm that Rej is the parameters that allows scale up (together 
with Da, that is related to the concentration); the geometrical ratio Dc/dj is also 
relevant. The other Da based on residence time and growth seems to play a minor 
role in the cases considered. 
For nanocapsules, MR comes out to be the other most important parameter 
(see Figure 4.12), thus suggesting that Rej and the ratio of the two characteristic time 
of oil drop and polymer film formation are the most relevant dimensionless 
numbers. Thus in this case it is the interaction of the two demixing processes to 
control phenomena, and not the interaction between nucleation and turbulence. 
In Figure 4.8a and Figure 4.8b results for nanospheres are shown. Data 
obtained at the same concentration with different geometrically similar mixers can 
be related by Reynolds number with a slope -0.2. In the case of CIJM-d2 having a 
different Δ values, a different curve is obtained. It can be noted that respectively at 
the same jet velocity, smaller particles are obtained passing progressively from 
CIJM-d1 to CIJM scale up and to CIJM-d2. Thus a larger interaction zone of the two 
streams seems favourable. In nanocapsule formation (Figure 4.8c and Figure 4.8d) 
the slope is lower than in nanospheres, as discussed before. 
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Figure 4.12. Dependence of nanocapsule size on copolymer/oil MR; copolymer concentration hold 
constant, 6 mg/ml. Upper graph: with quench; the data refer to the four CIJ mixers, including CIJ-
d2. Bottom graph  without quench: the data refer to the three scaled CIJ mixers only. 
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In Figure 4.11 all nanocapsule data obtained at MR=1.26 in the different CIJMs 
are reported as a function of Reynolds number. Nanocapsules obtained without 
quench are 30% bigger than the quenched ones. The ratio Dc/dj influences final size 
only in case of not quenched nanocapsules. That can be due to the fact that when 
Dc/dj decreases, mixing efficiency decreases as CFD simulations show (Lince et al. 
2011a) and reaction volume is no more completely contained in the mixer volume. It 
is probably that particles continue to grow outside the mixer, when not quenched 
with water, and data show that these increasing is higher with CIJM-d2, maybe due 
to less efficient mixing. 
The effect of MR is shown in Figure 4.12. The two proposed relationships for 
nanospheres and for nanocapsules are reported here: 
(NS) αβ )(Re0 polNSp cdd =                                                                                              (9) 
(NC) εβ )(Re0 MRdd NSp =                                                                                           (10) 
where α is 0.20 (as discussed before) and ε is -0.14 for quenched samples (calculated 
from non-linear regression of experimental data). 
In Figure 4.13 the effect of the total concentration in nanocapsule samples is 
shown. Nanocapsules at MR=0.76 were obtained changing the concentration of 
copolymer and of oil (values are reported in the caption of the figure). The total 
concentration does not affect significantly the final size, confirming that what it is 
important is the MR between the two components, and not the total component 
amount. This is true if the concentration of the polymer is sufficiently high (that is 
MR not much higher than 1). Data obtained at MR>2 show that very large increases 
can occur, but this is probably related to the coalescence of the droplet not 
considered here. 
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Figure 4.13. Dependence of nanocapsule size on oil and copolymer inlet concentration, at constant 
concentration ratio (MR = 0.76): 6 mg/ml and 4.8 µL/ml (square symbol), 10 mg /ml and 8 µL/ml 
(triangle symbol), 4 mg/ml and 3.2 µL/ml (circle symbol). Filled symbols, quenched; open 
symbols, not quenched . CIJ mixers; measured after solvent evaporation.   
4.3.5. Vortex mixers 
As a final consideration, it can be reminded that, as shown in the nanosphere 
section, it is possible to operate at different W/A ratio. This possibility can be 
desirable in case the formulation becomes more complex or need a different feeding 
of the chemical components in the solutions. What CFD simulations show and what 
our experimental results confirm, is that in CIJMs a W/A ≠ 1 affects mixing 
efficiency, resulting in a worst result. In principle, vortex mixer allows to overcome 
these limitations, since mixing efficiency does not depends on the two momenta of 
the fluids, so that it is possible to vary the W/A ratio without affecting mixing 
efficiency. Preliminary text in a vortex mixer with two and four inlet jets confirms 
that MIVM can be competitive with CIJMs in nanoprecipitation processes. 
Nanospheres were produced in VM-2 and VM-4 and results are shown in Figure 
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4.13a. Different connections have been texted and results show there are no 
significant differences working with different connextions while VM-2 looks to have 
a better performance than VM-4. In Figure 4.13b nanosphere size obtained in 
alternated VM-4 at different W/A ratios is shown. Unlike CIJMs, VMs used with 
W/A ratio >1 gives better results than working at W/A=1, as expected from the 
way the two jets mix in the chamber in the two different systems. 
0.01 0.1 1100
1000
0.01 0.1 1
 
 
si
ze
, n
m
vj, m/s
a)
 
 
vj, m/s
b)
 
Figure 4.14. Nanospheres from polymer concentration of 6 mg/ml. a) Comparison of CIJM-d1 and 
Vortex mixer at different inlet feeding for the production of nanospheres: CIJM-d1 (), VM-2 (), 
VM-4 with alternated connextions () and VM-4 with adjacent connections (). Polymer 
concentration = 6 mg/ml; quenched, measured after solvent evaporation. b) Comparison between 
alternated VM-4 at W/A=1 () and at W/A=2 (). 
4.4. Conclusions 
Results obtained in nanospheres and nanocapsules precipitation in CIJMs 
show that Damkhöler and Reynolds number can be used to relate particle size at 
different conditions, like initial copolymer concentration and flow rate. The effect of 
after-synthesis processes has also been investigated, in order to highlight that 
requested treatments or particular conditions can affect the final nanoparticle size. 
The use of quenching reduces nanoparticle size and allow to obtain nanospheres 
and nanocapsules in a reproducible way. Reproducibility is very important in 
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industry and must be reminded that the use of devices that allow continuous 
processes is very favourable in this respect. 
Data obtained by different mixers can be related through Reynolds number. In 
nanospheres the dependence on fluidodynamic is stronger than in nanocapsule 
formation, where phenomena involved are not well understood as in nanosphere 
precipitation. Mixing chamber and inlet jet diameter influence are here investigated: 
their effect in nanocapsule formation is still not well completely cleared out, but 
data show that at the same inlet jet velocity a bigger inlet diameter give better 
results, while the opposite is true in nanosphere precipitation. Inlet velocity remains 
an important parameter in affecting final particle size, but in nanocapsules the final 
result is a combination of different factors. 
Preliminary investigation on vortex mixer gives new prospective on the 
production of nanoparticles through micromixers. Mixing efficiency is reached 
without an impinging plane and vortex mixer offer more possibilities of 
combination to mix liquids, providing more interesting prospective in this field of 
investigation. 
The current analysis can be extended to different polymers and solvent, 
allowing to gather information on relative velocity of the different involved 
phenomena, allowing to compare kinetics from different polymers. 
  96 
4.5. References 
Akbulut M., Ginart P., Gindy M.E., Theriault C., Chin K.H., Soboyejo W., 
Prud’homme R.K., 2009. Generic method of preparing multifunctional fluorescent 
nanoparticles using flash nanoprecipitation, Advanced Functional Materials 19, 718–
725. 
Cheng J.C., Olsen M.G., Fox R.O., 2009. A microscale multi-inlet vortex 
nanoprecipitation reactor: Turbulence measurement and simulation. Applied Physics 
Letters 94, 204104. 
Cheng J.C, Fox R.O., 2010. Kinetic modelling of nanoprecipitation using CFD 
coupled with a population balance. Industrial and Engineering Chemistry Research 49, 
10651-10662. 
Fessi H., Puisiex F., Devissaguet J.P., 1989. Nanocapsule formation by 
interfacial polymer deposition following solvent displacement, International Journal 
of Pharmaceutics 55, R1-R4. 
Gavi E., Marchisio D.L., Barresi A.A., 2007, CFD modeling and scale up of 
Confined Impinging Jets Reactor, Chemical Engineering Science 62, 2228-2241. 
Gavi E., Marchisio D.L., Barresi A.A., 2008, On the importance of mixing for 
the production of nanoparticles, Journal of Dispersion Science and Technology 29 (4), 
548-554. 
Gavi E., Marchisio D.L, Barresi A.A, Olsen M.G, Fox R.O, 2010, Turbulent 
precipitation in micromixers: CFD simulation and flow field validation, Chemical 
Engineering Research & Design 88,  1182-1193. 
 97 
Gradl J., Schwarzer H.C., Schwertfirm F., Manhart M., Peukert W., 2006. 
Precipitation of nanoparticles in a T-mixer: Coupling the particle population 
dynamics with hydrodynamics through direct numerical simulation. Chemical 
Engineering and Processes 45, 908–916. 
Hussain M., Ceccarelli R., Marchisio D.L., Fino D., Russo N., Geobaldo F., 
2010, Synthesis, characterization, and photocatalytic application of novel TiO2 
nanoparticles, Chemical Engineering Journal Vol. 157(1), 45-51. 
Icardi M., Gavi E., Marchisio D.L., Barresi A.A., Olsen M.G., Fox R.O., Lakehal 
D., 2011, Investigation of the flow field in a three dimensional Confined Impinging 
Jets Reactor by means of microPIV and DNS, Chemical Engineering Journal 166, 294-
305. 
Johnson B.K., Prud'homme R.K., 2003a. Flash NanoPrecipitation of organic 
actives and block copolymers using a confined impinging jets mixer. Australian 
Journal of Chemistry 56, 1021-1024. 
Johnson B.K., Prud'homme R.K., 2003b. Chemical processing and micromixing 
in confined impinging jets. AIChE Journal 49, 2264-2282. 
Johnson B.K., Prud’homme R.K., 2003c, Mechanism for rapid self-assembly of 
block copolymer nanoparticles, Physical Review Letters 91 1183021. 
Lince F., Marchisio D.L., Barresi A.A., 2008, Strategies to control the particle 
size distribution of poly-e-Caprolactone nanoparticles for pharmaceutical 
applications, Journal of Colloid and Interface Science 332 (2), 505-515. 
  98 
Lince F., Marchisio D.L., Barresi A.A., 2009. Smart mixers and reactors for the 
production of pharmaceutical nanoparticles: Proof of concept. Chemical Engineering 
Research & Design 87, 543-549. 
Lince F., 2010. Preparation and characterization of polymeric nanoparticles for 
pharmaceutical applications. PhD Thesis. 
Lince F., Marchisio D.L., Barresi A.A. 2011a. A comparative study for 
nanoparticle production with passive mixers via solvent-displacement: Use of CFD 
models for optimization and design. Chemical Engineering and Processing 50, 356–368. 
Lince F., Bolognesi S., Marchisio D.L., Stella B., Dosio F., Barresi A.A., Cattel L., 
2011b. Preparation of poly(MePEGCA-co-HDCA) nanoparticles with Confined 
Impinging Jets Reactor: experimental and modeling study. Journal of Pharmaceutical 
Science 100, 2391-2405. 
Liu Y. and Fox R.O., 2006, CFD predictions for chemical processing in a 
Confined Impinging-Jets Reactor. AICHE Journal 52, 1877-1887. 
Liu Y., Olsen M.G., Fox R.O., 2009. Turbulence in a microscale planar confined 
impinging-jets reactor. Lab on a Chip 9, 1110–1118. 
Marchisio D.L., Rivautella L., Barresi A.A., 2006, Design and scale-up of 
chemical reactors for nanoparticle precipitation., AICHE Journal 52 (5), 1877- 1887. 
Marchisio D.L., Omegna F., Barresi A.A., Bowen P., 2008, Effect of mixing and 
other operating parameters in sol-gel processes, Industrial & Engineering Chemistry 
Research 47 (19), 7202-7210. 
 99 
Marchisio D.L, Omegna F., Barresi A.A., 2009, Production of TiO2 
nanoparticles with controlled characteristics by means of a Vortex Reactor, Chemical 
Engineering Journal 146 (3), 456-465. 
Peracchia M.T., Vauthier C., Desmaele D., Gulik A., Dedieu J.C., Demoy M., 
d'Angelo J., Couvreur P. 1998. Pegylated nanoparticles from a novel 
methoxypolyethylene glycol cyanoacrylate hexadecyl cyanoacrylate amphiphilic 
copolymer. Pharmaceutical Research 15, 550-556. 
Vauthier C., Labarre D., Ponchel G. 2007. Design aspects of 
poly(alkylcyanoacrylate) nanoparticles for drug delivery. Journal of Drug Targeting 
15, 641-663. 
 
 
 
  100 
5. Nanoparticle advanced characterization   
5.1. Introduction 
Nanospheres and nanocapsules were characterized in term of their 
morphological aspects. Transmission electron microscopy (TEM) is a common 
technique used for this purpose for the high resolution it can reach. TEM uses a 
beam of electrons which pass through an ultra thin specimen and returns back an 
image formed from the interaction of the electrons with the specimen.  The high 
resolution is due to the small de Broglie wavelength of electrons, which enables to 
detect fine details. TEM investigation were performed to confirm particle formation, 
as well as their size and their shape, and in order to gain more information about 
our product, such as surface morphology and copolymer behaviour in 
nanoprecipitation process. Scanning electron microscopy (SEM) was also used in a 
first attempt to characterize both nanospheres and nanocapsules, but it was 
successful only with nanospheres. 
X-ray photonelectron spectroscopy (XPS) is a quantitave technique which 
measures elemental composition of a material. It irradiates the sample with a beam 
of X-rays while simultaneously measuring the kinetic energy and number of 
electrons escaping from the sample. 
It has been known for a long time that the XPS analysis provides 
semiquantitative information about the atomic percentage of elements in close 
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proximity to the surface, and that the chemical bonds between the elements of a 
polymeric material compound can be studied thoroughly. 
The purpose of the characterization by XPS was to investigate the effectiveness 
of angle resolved XPS analyses, as well in depth profiles, for the estimation of the 
thickness of the nanocapsule walls. 
5.2. Materials and methods 
5.2.1. Materials and operating conditions 
Nanospheres were prepared from an acetone solution of copolymer with an 
initial concentration of 6 mg/ml by using CIJM-d1. Only not quenched nanospheres 
were analysed with XPS, whereas quenched and not quenched ones were observed 
by TEM and SEM. 
Nanocapsules were produced from an acetone solution of copolymer with an 
initial concentration of 6 mg/ml and with 8 µl/ml (MR = 1.26) by CIJM-d1 with and 
without quenching. In order to study wall characteristics of nanocapsules, also 
nanocapsules at MR 0.76 (6 mg/ml and 4.8 µl/ml) and 2.37 (6 mg/ml and 15 µl/ml) 
were produced. The procedure is the one described in Chapter 3.3. 
All the samples characterized by XPS and TEM were produced using a flow 
rate of 120 ml/min.  
5.2.2. Preparation for XPS analysis 
A drop of polymeric nanosphere and nanocapsule suspension was deposited 
on a Silicon substrate for the XPS analyses. 
One can suppose safely that the substrate do not affect the investigations of the 
nanospheres and nanocapsules since the Silicon peaks have different binding 
energies with respect to those of the polymer elements.  
The drop of polymeric material, deposited on Silicon substrate, was dried for 
one day in an dryer and, after this procedure, it remained for 12 hours in the XPS 
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pre-chamber, under vacuum conditions, in order to outgas all the volatile 
components of the polymer before XPS analyses were undertaken.  
Initially, a SXI (secondary X-ray generated image) in situ analysis was 
performed, in order to have an overview of the sample surface and to carry out the 
analysis on a homogeneous area. 
5.2.3. Preparation for TEM analysis 
TEM observations were performed according to two different preparation 
methods. The first one consisted on a negative fixation which allows the imaging of 
thinly spread particulate material by surrounding it with a heavy metal-containing 
salt solution. The differential electron scattering by the heavy metal stain versus the 
lower atomic mass content of the polymeric material generates reverse-contrast 
negative electron images (e.g. nanospheres/nanocapsules should appear as white 
particles surrounded by dark areas). Specifically for the negative staining, a 
phosphotungstid acid (PTA) solution 4% was prepared with 4 g of PTA and 96 g of 
milliQ water (solution A). Staining solution was prepared by diluting solution A 
with ethanol 100% in a proportion 1 to 4 and added to the aqueous 
nanosphere/nanocapsule suspension. A drop of the final mixture was deposited on 
a copper grid covered by a carbon film and dried at ambient temperature before 
observation. 
“Positive” images (e.g. nanocapsules appear dark and the surroundings are 
bright) were obtained from the second preparation method. In this case, a drop of 
the particulate suspension was directly deposited on the film grid and observed 
after drying. The contrast is lower than in the negativated samples, but the 
specimen thickness becomes smaller and consequently more details become visible. 
Shadowing with Pt/C at an angle of 15º was in some cases performed in order to 
observe surface details and to get information on thickness of the specimen.  A 
schematic representation of this sample preparation is shown in Figure 5.1. 
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Figure 5.1. Schematic representation of shadowing with platinum. According to the angle the 
metal hits the surface, there will be an area not covered close to the particle, forming the 
“shadow” of the particle. 
5.2.4. Characterization 
X-ray Photoelectron Spectroscopy 
The X-ray Photoelectron Spectroscopy is a VersaProbe5000 (Physical 
Electronics) Scanning ESCA Microprobe, with a monochromatic X-ray beam, Al 
source (1486.6 eV). The instrument calibration is performed by matching the 
literature binding energy values of Au 4f7/2, Cu 2p3/2 and Ag 3d5/2 peaks  
(Powell, 1995). 
 Data (counts of photoelectrons emitted for second, versus energy binding) 
were acquired with the Summit 1.3.6 software and the fitting calculations were 
carried out with the Mulipak software version 9.2. 
A 100 mm X-ray diameter spot size, with a power of 25.6 W, on a rectangular 
area of 100 mm x 800 mm, was employed in order to avoid corruption of the 
polymer characteristics.  
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During the data acquisition a double neutralization system was employed in 
order to avoid charging effects on the non conductive polymeric surface. The 
neutralization system  consists in an Argon ion gun combined with an electron gun. 
The energy resolution achieved, with VersaProbe, on polymeric materials, is 
0.85 eV. 
 
Transmission electron microscopy 
Morphologic observations of nanoparticles and nanocapsules were carried out 
with a Philips TECNAI 10 transmission electron microscope (TEM) at an 
accelerating voltage of 80 kV and a Focus Ion Beam Zeiss Neon 40 instrument for 
scanning micrographs. Carbon coating was accomplished by using a Mitec K950 
Sputter Coater (endowed with a film thickness monitor k150x). 
 
Scanning electron microscopy 
Nanospheres characterization was carried out also with a column scanning 
electron microscopy with field emission Shottky, 4pA-20nA, 0.1-30 kV, resolution 
1.1 nm. 
5.3. XPS results 
Survey scans on nanosphere and nanocapsule samples were acquired from 0 
eV to 1200 eV, as the main spectral features of the elements in polymeric materials 
under investigation fall within this energy range. The results show the typical 
spectra of polymeric materials with O1s, C1s and N1s main peaks, as clarified  in 
the survey scans reported in Figure 5.2: 
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Figure 5.2. Survey scan of nanoparticles surfaces: nanospheres (blue) and nanocapsules (red). 
The blue survey scans refers to nanosphere sample and the red scan to 
nanocapsule sample and both report typical XPS spectra of polymeric materials, 
with a huge amounts of carbon signal at 284.8 eV combined with oxygen peak at 
532.3 eV. 
The presence of the oxygen peak is confirmed by the OKLL Auger peak, at 
higher energy binding (980 eV). The intensity of the Auger peaks is strictly related 
to the intensity of O1s signals. It is present a nitrogen peak, with lower intensities,  
as we expected, from the chemical composition of the polymer. Standard procedure 
for the atomic % calculation is used in order to have a semi-quantitative information 
of each element. 
The formula adopted is reported in Equation 1 
N
i
ii
CC
fI
fIatomic
Σ
=%                                                                                                    (1) 
where I is the area under the curve (the subscript indicates the element, C stands for 
carbon, for example) and f is the sensitivity factor of the element, which allows to 
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keep into account the sensitivity of each elements to the radiation. Element 
sensitivity depends basically on the atomic weight (lower atomic weight elements 
have lower sensitivity) but also on other variables, like the incident angle of the 
radiation. 
The semi-quantitative information about surface composition of non quenched 
samples is reported in the table below: 
Elements Nanospheres (%) Nanocapsules (%) 
N1s 3.5 1.6 
O1s 16.2 16.9 
C1s 80.3 81.4 
 
It can be noted that the ratio between the atomic percentage of C1s and O1s 
peak is the same in nanocapsule and nanosphere samples while a higher amount of 
N1s signal in the nanosphere material (3.5%) compared to the nanocapsules sample 
(1.6%). 
The high resolution scans, acquired with a pass energy of 23.5 eV, in limited 
range of energy, were carried out on C1s, O1s and N1s in order to study the 
chemical bonds between these atoms located on the surface layer. On nanospheres 
and nanocapsules there is evidence of the C1s region which comprises three 
components: 1) direct C-C bound, 2) C-O and C≡N bound and 3) O-C=O. Energy 
binding at 286 eV may correspond to a single bond C-O as well as to a triple bond 
CN. After the fitting procedure, it is possible to have an estimation of the percentage 
of each bond. According to Peracchia et al. (1998), the C-O bond is assigned to PEG. 
There is a larger amount of C-O and CN bound (27.9%) in the nanosphere samples 
compared to the amount  (18.7%) in the nanocapsule samples and 4.7% of O-C=O in 
the nanosphere sample compared to 9.7% in the nanocapsule sample. As reference 
also the pure polymer was analyzed: a drop of a polymer solution was dried and 
analyzed at XPS (see Figure 5.3). Its results represent a random distribution of 
chains, where polymer chains does not arrange in a “frozen” state like in 
nanospheres and nanocapsules.             
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Figure 5.3. Surface analysis of carbon region in: a) pure polymer, b) nanospheres and c) 
nanocapsules. Relative atomic percentage of carbon bonds are reported on the figure. Samples are 
not quenched. 
It has to be noted the C-O bond and CN bond have the same energy binding: 
in Peracchia et al. (1998) that peak is attributed just to C-O bond of PEG, without 
considering the contribution of CN bond. The C-O bond is surely predominant in 
polymer structure, but comparing nitrogen spectra with carbon spectra of both 
samples (nanospheres and nanocapsules) it can be said, without any doubt, that also 
CN bond contribution is present in that peak (see Figure 5.4). Attribution is 
confirmed by the behavior of the intensity peak of nitrogen, which decreases 
proportionally like carbon shoulder (286 eV). 
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Figure 5.4. Carbon and nitrogen spectra of pure polymer, nanospheres and nanocapsules. Red 
spectrum is pure polymer, black spectrum is nanosphere sample, blue spectrum is nanocapsule 
sample. 
The angle resolved XPS analysis provide information about the first 8.5 nm in 
non-destructive mode, tilting the sample from 10° degree to 90° degree with a 10º 
degree step. A constant behaviour of carboxylic groups is obtained in the outer layer 
(8.5 nm thick) for both samples (nanospheres and nanocapsules), as reported in the 
following layout. 
 
Figure 5.5. Angle resolved analysis of nanospheres (left) and nanocapsules (right). Atomic 
concentration versus sin theta. Theta is the angle of the sample with respect to the analyzer.  
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Figure 5.5 (Angle Resolved nanospheres and nanocapules) reports the atomic 
percentage information of single bond corresponding to the thickness where the 
information come out. The atomic percentage values are in agreement with the 
values obtained with the standard surface and  the depth profiles analysis. 
During the depth profiles analysis a C60 gun is employed in order to have an 
information regarding the behaviour of the bonds versus depth. During this 
analysis a C60 gun bombards the surface removing layer of material, giving us an 
information about the internal part of the polymer (3.5 nm/min etch rate). In 
nanosphere samples it can be noted a strong decrease of the C-C bond and a relative 
increase of the C-O signal. In the nanocapsules there is a different behavior: an 
instantaneous increment of both C-C and C-O signal versus an asymptotic constant 
behavior. 
 
Figure 5.6. Depth profile using C60 gun. Sputter time is the time of C60 on the sample. 
On the contrary, with Argon gun, adopted during the preliminary 
investigation, in depth profiles mode, it was noted the break C-O polymeric chains, 
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due to the interaction with small dimension of the Argon ion, and consequently a 
distortion of the information relative to these investigations.  
Figure 5.7. Depth profile using Argon gun: nanospheres (left) and nanocapsules (right). 
In the following part, we will focus our attention on nanocapsules. 
Nanocapsules have a liquid core, surrounded by a polymeric layer. As core we 
use Miglyol® 812N, which is a mixture of fatty acids and glycerol. In nanocapsules 
with PEG the hexadecyl chains are in contact with the hydrophobic core, whereas 
the PEG chains stretch out. 
The XPS angle resolved analysis is more sensitive to the surface and it is 
possible to obtain chemical information from the surface to a  thickness of 8.5 nm, in 
a non-destructive mode. 
Starting from the Oxygen peak, it is visible a different behaviour between 
nanosphere samples and nanocapsule samples. Nanocapsule samples presented a 
higher shoulder at higher energy binding, than nanosphere samples. 
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Figure 5.8. Oxigen spectra of nanospheres (left graph) and nanocapsules (right graph) with the 
relative deconvolution process and the attribution to each bond. Nanospheres were obtained from 
6 mg/ml solution and nanocapsules from 6 mg/ml and 8 µL/ml. Not quenched samples. 
In nanosphere spectra signal deconvolution shows two different contributions: 
the main peak (532,4 eV) related to the Oxygen signal of the material, and the left 
shoulder (533.6 eV), at higher energy binding, related to PEG signal. 
In nanocapsule signals the main O1s peak (532.3 eV) is attributed to the 
oxygen signal of the material, but the shoulder at higher energy binding (533.6 eV) 
could be  related  not only to PEG but also to oil signal. This result could be 
attributed to the oil signal coming from the core of the nanocapsules, that has the 
same energy binding value as the PEG signal. Consequently, it was tried to analyze 
the thickness of the nanocapsule shells studying the behaviour of the intensities 
related to the shoulder at higher energy binding. Furthermore there was evidence of 
a significant change in oxygen profile and this change occurs at different depth 
according to the MR value investigated.  
The tilted condition of the samples respect to the analyzer ranged from 10 to 90 
degrees. In Figure 5.9 the right-hand column shows the quenched and the left-hand 
column shows the unquenched nanocapsules. In each panel the first spectra was 
acquired at 10° and the following spectra were recorded to 90° with a 10° tilting step 
respect to the analyzer. This step was gradually increased to 90°. These lines are 
plotted from the bottom of the picture and shifted in the z direction towards the top. 
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The big variation of the shoulder intensities ratio changes proportionally with the 
nanocapsule oil to polymer mass ratio (MR) from radent surface to bulk (8.5 nm). 
According to Leber and Ratner (2009) the information depth on PEG ranges until 8.5 
nm. 
The intensity difference between main O1s peak and shoulder, at higher 
energy binding, changed proportionally to the MR. When the signals comes from 
the topmost layer (theta=10°) there is always the same intensity of two O1s peaks at 
532.5 eV and 533.7 eV. 
When theta increases and consequently the information come from deeper 
layer, the left shoulder at 533.7 eV decreases, and this could be related to the end 
point of the nanocapsule wall. In quenched nanocapules, this O1s left shoulder 
intensity reduction happens in deeper layer, this indicating thicker nanocapsule 
wall. According to the literature, the angle resolved information gives chemical 
information until 8.5 nm on PEG based materials. It can be calculated the depth 
where this variation of left O1s peak intensity start to decrease and calculate the 
depth where this information come out and consequently the nanocapsule wall 
thickness. The formula used is: 
thickness (nm)=8.5*sinϑ 
Whenever the intensity of the shoulder is comparable with the O1s one we do 
expect that the record signal is due walls nanoparticles. On the contrary when the 
shoulder intensities start to decrease it means that no more signal comes from the 
wall nanoparticles, but only form the oil internal part. 
In the quenched nanocapsules with MR=2.37 there is the same intensity in the 
shoulder at (533.7  eV) and the main O1s peak until 3/9 angle acquisition (4.25 nm). 
In the intermediate MR value this variation of intensities starts form 9/9 (8.5 
nm) and in MR=0.76 there is always the same intensities. In the last case it is 
possible to assume that the wall thickness is, surely, thicker than 8.5 nm. 
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Figure 5.9. XPS analysis at different angles (from 10º to 90º) of nanocapsules at different MR 
without quenching (left column) and with quenching (right column). From the top: nanocapsules 
at MR 2.37, at MR 1.26 and at MR 0.76. In each graph are reported nine oxygen peaks obtained at 
different angle, from the bottom to the top: 10º, 20º, 30º, 40º, 50º, 60º, 70º, 80º and 90º. A line 
highlights where the oxygen profile changes, indicating a change in chemical composition. 
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In the non-quenched nanocapsules, where the average of the wall thickness is 
lower, we obtain the same trend: the same shoulder intensities until  1/9 (1,44 nm), 
for nanocapsules at MR=2.37, 4/9 (5,44 nm) for MR=1.26 and 8/9 ( 8,33 nm) for 
MR=0.76 one. All these values are reported in Table 5.1: 
Table 5.1. Estimated value of polymer wall at different MR values with and without quenching. 
  Non quenched, nm Quenched, nm 
MR 2.37 1.44 4.25 
MR 1.26 5.44 8,5 
MR 0.76 8.33                 >8.5 
 
The quenched nanocapsules shows thicker walls respect to the non-quenched 
nanocapsules. That can be explained as that, diluting by water, medium 
composition changes having a bigger fraction of water that results in reduced 
polymer solubility which precipitates around nanocapsules, but this will be 
discussed in more details in the discussion. 
5.4. TEM results  
Figure 5.10 shows nanocapsule photos both “positive” (a, c) and “negative” (b, 
d). TEM analysis confirmed spherical shape of the nanocapsules and their size 
dimensions. Two MR were analysed by TEM: 1.26 and 0.76. The bigger amount of 
oil in MR=2.37 was considered dangerous for the equipment, due to the higher oil 
quantity, and no samples were analysed. 
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Figure 5.10. Positive (a, c) and negative (b, d) TEM micrographs taken at different magnifications 
of poly(MePEGCA-co-HDCA) nanocapsules containing Miglyol  812. Samples were prepared 
with MR = 1.26, FR = 120 ml/min and initial copolymer and oil concentrations of 6 mg/ml and 8 
µL/ml, respectively. Blue arrows point out the pseudoregular geometries that can be observed 
inside the capsules, probably as a consequence of a regular arrangement of some oil molecules. 
Nanocapsules show a spherical shape with some regular geometries inside 
(blue arrows in the photos), which can be due to oil molecules, because, as it will be 
shown later nanospheres have a different shape. Acquisition of photos with TEM, 
under high vacuum conditions, was quite hard, due to the fact that the polymer was 
easily burnt by electrons and nanocapsules could break. An interesting image is 
shown in Figure 5.10c, where a nanocapsule clearly “exploided” leaving the oil 
outside. In many samples most of the nanocapsules showed an halo (see for 
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example Figure 5.11a) around the particle, which is due to the oil leakage. Figure 
5.11c and d were acquired while the electron radiation was burning the sample: in 
Figure 5.11c it is shown the fracture in the polymer wall, whereas in Figure 5.11d 
the polymer film is burnt on the surface letting see the internal structure which has 
pseudoregular geometries. Nanocapsule breakage and spilling out of the oil is 
common with nanocapsule structure (Guinebrietere et al., 2002). 
 
 
Figure 5.11. TEM micrographs taken at different magnifications of poly(MePEGCA-co-HDCA) 
nanocapsules containing Miglyol 812. Samples were prepared with MR = 0.76, FR = 120 ml/min 
and initial copolymer and oil concentrations of 6 mg/ml and 8 µL/ml, respectively. Sample (d) was 
shadowed with Pt/C. Red and black arrows point out pseudoregular geometries inside 
nanocapsules and spilled oil outside nanocapsules, respectively. Wall thickness of nanocapsules 
is indicated by the blue asides. 
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5.4.1. Nanosphere photos 
Nanospheres are constituted just by the polymer and are a monolytic 
structure. Differently from nanocapsules, they can be analyzed quite easily by SEM. 
Photo in Figure 5.12 shows nanospheres seen with SEM. Some of them are 
measured, confirming the size measured by dynamic light scattering. In the picture 
are also visible smaller nanospheres, highlighting there is a size distribution in the 
sample. 
Nanospheres photos show spherical nanoparticles. Some of them were 
measured by SEM, and average size of the measured ones is around 150 nm. 
Smaller nanospheres are present. In Figure 5.12b) size distribution measured by 
dynamic light scattering (DLS) is shown, both number distribution (solid line) and 
volume distribution (dashed lines) are reported. 
 
 
Figure 5.12. a) Nanosphere picture obtained with SEM. b) Particle size distribution of the sample 
measured by DLS: number distribution (─) and volume distribution (---).  
Nanospheres shadowed by Pt/C and seen at TEM are shown in Figure 5.13. 
The typical “shadow” of the technique is present, revealing the spherical shape of 
nanospheres. 
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Figure 5.13. Nanospheres covered with Pt. The large shadow indicate spherical shape of the 
sample. 
Positive and negative nanosphere samples are shown in Figure 5.14. It is 
noticeable that positive image reveals a particular morphology, like the nanosphere 
is  constituted by many smaller aggregates. This morphology is not evident in the 
negative image. It indicates that the surface is fragmented and the surface might be 
rough.  
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Figure 5.14. a) positive nanosphere sample; b) negative staining nanocapsule staining. 
5.5. Discussion 
Nanocapsules obtained at different MR oil/polymer were analyzed by XPS at 
variable angle in order to study the composition of the external layer and estimate 
polymer wall thickness. Nanospheres and nanocapsules analyzed in this work by 
XPS and TEM were all produced at 120 ml/min as flow rate, which is a value that 
ensures good mixing performance and reduces experimental variability. 
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XPS results suggest that increasing oil to polymer concentration (i.e. from MR 
2.37 to MR 0.76) nanocapsule thickness decreases in both the cases analyzed, with 
and without quenching. Without quenching polymer wall was estimated to vary 
from 1.44 nm (MR 2.37) to 8.33 nm (MR 0.76), while with quenching from 4.25 nm 
(MR 2.37) to over 8.5 nm (MR 0.76). In a solution at high MR there is less polymer in 
comparison to oil amount and polymer amount increases as MR decreases. In 
nanocapsules obtained from MR 2.37 polymer amount is very low with respect to 
the oil amount, so polymer wall will be thiner. On the contrary, when a high 
polymer quantity is available, polymer wall will be thicker. This conclusion is in 
agreement with what other authors reported (Cauchetier et al., 2003, Romero-Cano 
and Vincent, 2002) 
At the same time quenching nanocapsules resulted to be more thicker of the 
corresponding non quenched samples. Some solubility tests of the polymer at 
different water fraction were performed in order to highlight if a bigger percentage 
of water could modify residual solubility of the polymer (chapter 2). Test were 
performed at 30 ºC and solution at 50%, 66% and 90% water were investigated. Non 
quenched samples correspond to a 50% water fraction, while quenched sample to 
66% water fraction. Starting from acetone solution of the polymer, water was added 
and it was observed if precipitation happened. Results are shown in Figure 5.15. 
They show that solubility of the polymer is lower in 66% than in 50% mixture. It is 
possible that operating with quenching more polymer precipitates at the outlet of 
the mixture when diluting with water. Polymer tends to precipitate over 
nanocapsules already formed giving a thicker polymer wall.  
Nanocapsule samples at MR 1.26 (Figure 5.10) and 0.76 (Figure 5.11) with 
quenching were analyzed also by TEM. From images shown in Figure 5.11, polymer 
wall thickness was estimated. It is around 5 nm (for nanocapsules obtained at 
MR=0.76), while wall thickness estimation by XPS was >8.5 nm at the same 
conditions. The fact that it is >8.5 is due to that radiation was not able to go deeper 
than this thickness. In comparing the two results it is necessary to take into account 
that both the methods have some limitations. In TEM analysis the limit of the 
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measure is due to the easy error of the manual measurements. Moreover, the image 
quality was not perfect and some doubts on the real end of the wall are justifiable. 
Regarding the method used in XPS analysis, the limitations is that data about the 
depth reached at 90º is not available for the P(MePEGCA-co-HDCA) and the value 
used in this work (8.5 nm) is the one reported on literature about PEG based 
materials. 
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6. Drug loading and drug release 
6.1. Introduction 
Nanospheres and nanocapsules are pharmaceutical carriers for drug release. 
Thanks to their nanometric size they allow to reach target organs or tissues and 
accumulate there. Once in the target organs they releases the drug. Drug release is 
an interaction of different mechanisms which depend on the matrix and in drug 
characteristics. Nanospheres are monolytic structure where the drug is dispersed in 
the polymeric matrix, while in nanocapsules the drug is dissolved in the inner 
liquid. In the first case drug release is an interaction of two main mechanisms: 
diffusion of the drug through the polymer and degradation of polymer matrix. In 
nanocapsules drug release depends mainly on the partition coefficient between the 
inner liquid and the outer medium.  
To understand the complex mechanism of drug release is quite difficult. 
Different mechanisms occur simultaneously. In pharmaceutical field empirical and 
semiempirical models are usually used to describe drug release: 
• Zero-order kinetic 
• First order kinetic 
• Higuchi Equation 
• Hixson-Crowell equation 
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These models are, as said, empirical or semi-empirical, so that they allow to 
have a good approximation of experimental data obtained in the usual range of 
operating conditions.  
A detailed study of release should be performed in order to evaluate the 
mechanisms involved, but it is not part of this work. The interest of this chapter is to 
show results about loaded nanospheres and nanocapsules, in order to highlight the 
bahavior of the system in loading and release and to provide a direct comparison 
between the two systems obtained in the same conditions.  
In order to provide a good kinetic model it should be possible to quantify drug 
amount in every single particle, but this is quite difficult to determine 
experimentally. This is why usually drug release is modelled by using empirical 
and semiempirical approaches like the ones cited above. Higuchi model and first 
order model provided a discrete fitting of experimental data and results will be 
shown in this chapter. Mechanism release from microencapsulated drugs was 
mathematically modelled in detailed in the past. These systems considered drug 
microparticles surrounded by a polymeric wall (Manca and Rovaglio, 2003, Petitti et 
al., 2008). The system here presented is different. The drug used as model drug is 
Triclosan, a little lipophilic drug, with great affinity for the organic oil of the inner 
core of nanocapsules, while it is supposed triclosan precipitates simultaneously 
with the polymer in nanospheres synthesis, in order to be dispersed in the polymer 
matrix. 
6.2. Materials and method 
6.2.1. Materials 
Acetone Chromasolv® by Sigma Aldrich and ultrapure water produced by 
Millipore® were used as solvent and antisolvent for nanosphere and nanocapsules 
production. Triclosan by Sigma Aldrich was used as model drug. 
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Figure 6.1.  Chemical structure of Triclosan. 
6.2.2. Preparation of loaded nanoparticles 
Nanospheres and nanocapsules of poly(MePEGCA-co-HDCA) containing 
triclosan were prepared by the solvent displacement method using CIJM-d1. 
Nanospheres at 6 mg/ml and nanocapsules at MR 1.26 (6 mg /ml polymer 
concentration and 8 µL/ml oil concentration) were loaded with triclosan. Triclosan 
was added to acetone solution in order to have 0.3% (w/v) of triclosan (3 mg/ml). 
25 ml of this solution were injected into the mixer together with 25 ml of water and 
quenched in 25 ml of water kept in magnetic stirring at the out of the mixer. Two 
flow rates were investigated: 120 ml/min and 10 ml/min. Finally, the acetone was 
rotaevaporated (30 minutes at room temperature) to get an aqueous suspension of 
nanospheres. 
Nanocapsules were prepared following the same methodology after adding 8 
µl/ml of Miglyol 812 to the initial organic solution of the copolymer in order to 
form the inner oily cavity. 
Nanoparticle and nanocapsule suspensions were extensively dialyzed 
(Spectra/Por® 3500 MWCO dialysis membrane, Spectrum, Huston, TX) during 4 
hours against a Sörensen solution supplemented with 10% (v/v) of ethanol in order 
to remove all non loaded triclosan. Aliquots of 200 µL of the sample suspension 
after dialysis were sonicated and extracted with 1 ml of 70% ethanol to quantify 
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triclosan by UV analysis. From this value it was measured the total amount of 
triclosan that was incorporated in nanospheres and nanocapsules. Drug 
incorporation percentage (%TCSINC) is calculated from equation 1: 
TOT
INC
INC nmgTriclosa
nmgTriclosaTCS =%                                                                                         (1) 
Drug loading was calculated as the drug incorporation percentage over the 
total amount mass amount: 
INC
INC
NS nmgTriclosamgPolymer
nmgTriclosaDL
+
=%                                                                       (2) 
INC
INC
NC nmgTriclosamgOilmgPolymer
nmgTriclosaDL
++
=%                                                       (3) 
An UV-3600 spectrophotometer controlled by the UVProbe v2.31 software 
(Shimadzu, Tokyo, Japan) was employed. Calibration curves were obtained by 
plotting the absorbance measured at 281 nm against triclosan concentration.  
In the same conditions (of concentrations and flow rate), precipitations of 
nanospheres and nanocapsules were carried out and particle size was measured by 
DLS after solvent evaporation and an average value is reported in the following 
section. 
6.2.3. Drug release 
10 ml of the aqueous suspension containing triclosan-loaded nanoparticles or 
nanocapsules (3 mg/ml of triclosan) were confined in a dialysis bag, which was 
introduced in a vessel provided of magnetic stirring and containing  20 ml of the 
selected release medium. This consisted on a mixture (3/7 v/v) of Sörensen 
medium (pH 7.4) and ethanol. Aliquots (1 ml) were drawn at predetermined 
intervals to determine the amount of released triclosan by UV spectroscopy. The 
volume of the release medium was kept constant by addition of 1 ml of fresh 
medium after removal of each aliquot.  All drug release tests were carried out using 
five replicates to control the homogeneity of the release and to average the results. 
The triclosan remaining in the samples was determined again by UV analysis. In 
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this case, aliquots (200 µl) of the dialysis bag sample were sonicated and extracted 
with 1 ml of 70% ethanol which ensures complete dissolution of triclosan.  
Higuchi model and first order model were used to fit data. Higuchi equation is 
2/1tKQ H=                                                                                                               (4) 
where Q is the total drug amount released, KH is the Higuchi constant and t is time 
in hours. Data are plotted as the cumulative percentage of drug released versus the 
square root of time in hours. 
First order equation in drug release is expressed as follows 
 303.2/0 KtLogCLogC −=                                                                                    (5) 
where C is drug concentration in the release medium at time t, C0 is the initial 
concentration of drug in the dosage form, K is the kinetic constant and t is time in 
hours. The data obtained are plotted as log cumulative percentage of drug 
remaining vs. time which would yield a straight line with a slope of -K/2.303. 
 
6.2.4. Antibacterial activity 
The in-vitro antibacterial activity of nanoparticles and nanocapsules loaded 
with triclosan was evaluated using the Gram-positive Micrococcus luteus (M. 
luteus) (CECT 245, Spanish Collection of Type Culture, Valencia, Spain) and Gram-
negative Escherichia coli (E. coli) (CECT 101, Spanish Collection of Type Culture, 
Valencia, Spain) microorganisms. 
Briefly, 7 ml of Luria-Bertani (LB) broth containing 105 CFU/ml was mixed 
into sterile tubes with 1 ml of the nanoparticle or nanocapsule aqueous suspension. 
Tubes were inverted 4-6 times to assure mixing and incubated for 24 h and 48 h in a 
shaking incubator at 100 rpm and a temperature of 37 ºC. Cultures of LB broth 
without and with bacteria were performed as the negative and the maximum 
bacterial growth controls, respectively. Culture of pure LB broth was the negative 
control, and pure LB broth with nanoparticles or nanocapsules were also tested as 
blank of turbidity. 
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The bacterial growth was determined by measuring the turbidity at 600 nm by 
UV spectroscopy. The surviving number of bacteria was determined according to 
the relative growth rate (percentage) calculated from turbidity changes after 24 h 
and 48 h of incubation. Activities were evaluated using six replicates, in each case 
the corresponding average value and standard deviation being determined. Two 
samples were considered statistically significantly different when ANOVA and χ2-
test gave p ≤ 0.05. 
The antibacterial effect in manner doses-response was also determined for 
nanocapsules loaded with triclosan. For it, different dilutions of the sample were 
evaluated and the relative growth evaluated as noted above. The dose-response 
effect was analyzed according to a logistic model using OriginPro v8 software 
(Origin Microcal Corp., USA). 
6.3. Results 
6.3.1. Size 
Loaded nanospheres and nanocapsules were produced in quintuplicate at each 
conditions used in release experiments, in order to measure final particle size. 
Results are shown in Table 6.1. These data shows that loading with triclosan there is 
not a significant increase in particle size, if compared with results obtained with 
unloaded nanocapsules and nanospheres shown in Chapter 3. Nanospheres look to 
increase their size with respect to their trend in unloaded samples and this can be 
explained with the fact that in nanospheres the drug is not dissolved but dispersed 
in the polymeric matrix. As reported in Johnson and Prud’homme (2003), drug 
nucleation occurs simultaneously with polymeric nucleation, so that polymer can 
act as stabilizer for drug nuclei. The presence of drug nuclei could explain the 
bigger dimensions found in loaded nanospheres in comparison to the trend 
obtained with unloaded nanospheres. According to nucleation theory, drug should 
nucleate faster than polymer. It is difficult to see the structure of the nanospheres, 
but it is possible they have a solid core made of drug and a polymer layer around it. 
 129 
In nanocapsules this deviation from the size trend is not present and size data 
from loaded nanocapsules are in agreement with the data obtained with unloaded 
nanocapsules (see Chapeter 3). It has to be noted that Triclosan is highly lipophilic, 
being its water solubility <10-6 g/ml (Grove et al., 2003) and so its affinity for inner 
oil is great. 
Table 6.1. Mean particle size of nanospheres and nanocapsules loaded with triclosan. 
Nanocapsules   Nanospheres 
FR Size (nm) Std dev.   FR Size (nm) Std dev. 
120 234.13 8.40  120 161.14 12.35 
10 377.89 23.10   10 246.57 7.10 
 
6.3.2. Drug incorporation 
Drug amount is measured by UV from the sample after dialysis. Quantity 
found to be in nanoparticles are reported in Table 6.2. No significant differences can 
be found between drug incorporation in nanospheres and in nanocapsules. Just 
nanocapsules obtained at 10 ml/min have a lower triclosan incorporation.  
Drug loading is measured as the drug contribution to the total weight amount 
of the product. In this way it is straightforward that drug loading is always lower in 
nanocapsules than in nanospheres. It has to be noticed that the drug amount used is 
high (3 mg/ml), being drug mass 50% of the polymer mass used. For this reason 
drug loading also is high. 
Drug release from nanospheres and nanocapsules is shown in Figure 6.2. 
Release from nanospheres does not change from the ones obtained at lower flow 
rate and the ones obtained at higher flow rate. Release profile is the same. In 
nanocapsule sample the results are quite different between the two sample. As 
reported previously, nanocapsules obtained at 10 ml/min had a lower drug 
incorporation than the other samples, so it is difficult to compare the two results. 
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Table 6.2. Drug loading and drug incorporation of triclosan in nanospheres and nanocapsules. 
  
Flow Rate 
(ml/min) 
mg 
incorporated 
drug 
incorporation % 
drug loading 
%   
Nanospheres 10 61.01 86.54 30.20 
Nanospheres 120 64.82 91.94 31.49 
Nanocapsules 10 41.06 57.03 11.17 
Nanocapsules 120 65.42 90.86 16.70 
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Figure 6.2. Drug release from a) nanospheres, obtained at flow rate = 10 ml/min () and 120 
ml/min (□). b) nanocapsules, obtained at flow rate 10 ml/min () and 120 ml/min (). 
If the total amount of drug released is considered, the release curves as 
function of time appear like in Figure 6.3. The amount of drug released from 
nanospheres and nanocapsules is quite the same. It has to be taken into account that 
the volume precipitated was divided into 5 dialysis bags, and release data reported 
in Figure 6.3 are shown as milligrams released per millilitres of particle suspension. 
Drug release velocity was reported as mg/ml h during fixed intervals between 
following sampling, except in the first interval where it is the velocity in the first 
hour. In red are reported samples obtained at 10 ml/min and in black the ones at 
120 ml/min.  
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Figure 6.3. Drug released in mg/ml of suspension for nanospheres (upper graph) and for 
nanocapsules (lower graph): particle obtained at 10 ml/min (red) and at 120 ml/min (black). On 
right graph velocity of release is reported, as mg/h released in the different time interval. 
Drug release increases until 24 hours and then stabilizes to a constant value of 
release. As graphs of velocity (right column of Figure 6.3) show, velocity of release 
decreases until 120 hours, the last time of the experiment. Total drug amount is 
almost the same in all the sample, but in nanocapsules obtained at 10 ml/min (see 
Table 6.2). The quantity released is however the same in all the samples, meaning in 
case of nanocapsules obtained at 10 ml/min the depletion is almost 100% (as shown 
in Figure 6.2). Nanocapsules have a release profile slightly more sustained than 
nanospheres. It is necessary to remember always that drugs in nanospheres are in 
solid state in the matrix while in nanocapsules the drug is dissolved. The 
mechanism the drug gets out the nanosphere includes diffusion through the matrix, 
eventually through pores present in the matrix, while in nanocapsules it depends 
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mainly on the partition coefficient between the two liquids on the two sides of the 
polymer membrane. The slower release from nanocapsules can be explained as a 
greater affinity toward the inner core of the nanocapsules in comparison to the one 
of nanospheres.  
In order to highlight if there is any preponderant mechanism in the release, 
data were analyzed by the common methods used in pharmaceutical field. The best 
fitting is given by dividing the release curve into two parts in order to have linear 
dependence. In the first part of the curve the best fitting is given by Higuchi model, 
while in the second part first order method seems to give the best results (see Figure 
6.4). As shown previously, velocity of drug released increases until 17 hours and 
then decreases. At that point, over 50% of drug was released. Higuchi model gives a 
good fitting of this data set. In this first part of release some of the conditions of the 
model are, in fact, present: initial drug concentration in the matrix is much higher 
than drug solubility, matrix swelling and dissolution are negligible and perfect sink 
conditions are present. With time, concentration of drug in the release medium 
increases, avoiding the attaining of sink conditions and the concentration in the 
matrix decreases, becoming closer to the drug solubility. In our samples, as shown 
in Figure 6.5, particle degradation does not occur in a significant way, i.e. both 
nanospheres and nanocapsules are still present after release experiments. That 
means that in the time of release no significant degradation occurs, and this is a 
condition in Higuchi model, differently from the Hixson Crowell model which 
requires that particle volume and surface change with time due to erosion. 
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Figure 6.4. Release data fitted by Higuchi model and first order model. a) nanospheres data fitted 
by Higuchi model in the interval time 0-17 hours: nanospheres obtained at 10 ml/min (, red 
fitting curve) and 120 ml/min (, black fitting curve). b) nanospheres data fitted by first order 
model in the interval time 17-120 hours: nanospheres obtained at 10 ml/min (, dashed fitting 
curve) and 120 ml/min (, solid fitting curve) ; c) nanocapsules data fitted by Higuchi model in 
the interval time 0-17 hours: nanocapsules obtained at 10 ml/min (, dashed fitting curve) and 120 
ml/min (, solid fitting curve). d) nanocapsules data fitted by first order model in the interval 
time 17-120 hours: nanocapsules obtained at 10 ml/min (, dashed fitting curve) and 120 ml/min 
(, solid fitting curve).  
In the second part of drug release, when the release profile starts to be 
asymptotic, the model which best fits data is the first order model. The mechanism 
described by this model is quite difficult to conceptualize, but it is commonly used 
to describe dissolution of drugs in dosage forms. As it can be seen in Figure 6.4, 
nanocapsule data are fitted better than nanosphere data by first order model, 
confirming its application in the field of dissolved drugs.  
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Figure 6.5. Nanospheres (left) and nanocapsules (right) after release experiment. 
On these basis, a comparison of the release kinetics of triclosan from 
nanospheres and nanocapsules are shown in Figure 6.6. To compare the two system 
samples obtained at 120 ml/min are used. 
The maximum release of triclosan from the nanospheres and nanocapsules 
was near of 80% of the drug loaded, and it is achieved more quickly by the 
nanospheres, occurring approximately at 50 hours of the release. In the case of the 
nanocapsules, the maximum release was achieved after 120 hours of release. 
On the other hand, about 40% of the loaded drug was released quickly, before 
of the first 24 hours of release, being more rapid the drug release from nanospheres. 
In this initial release, the kinetic constants by Higuchi model were 0.1408 h-1/2 
(±0.02) and 0.1686 h-1(±0.03) for the nanocapsules and nanospheres, respectively. 
The following final phase (40-100% of drug release) occurred with kinetic constants 
(by first order model) of 0.0216 h-1 (±0.13) and 0.0215 h-1 (±0.43) for nanocapsules 
and nanospheres, respectively. These constants are increased when the drug affinity 
for the release medium increases, and this happens in the case of the nanospheres. 
The drug loaded in the nanospheres must be deposited in both the surface and 
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matrix, which explains why the drug release is faster in both the initial and final 
stage, and it must involve diffusion from the polymer matrix to the release medium. 
In contrast, the kinetic constants are lower for the nanocapsules, and this 
indicates that the drug affinity by the nanocapsules matrix is increased; this case is a 
logical consideration because the nanocapsule matrix is glycerol, and the affinity of 
the triclosan-glycerol system is greater than the triclosan-ethanol system. 
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Figure 6.6. Drug release from nanospheres () obtained from 6 mg/ml and FR=120 ml/min, and 
from nanocapsules () obtasined from 6 mg/ml (polymer) and 8 µL/ml (oil) at FR=120 ml/min.  
6.3.3. Antibacterial activity 
The antibacterial activity of the nanocapsules and nanospheres was tested by 
direct contact with microorganisms. The Figure 6.7 shows the relative growth of 
E.coli (Gram negative bacterium) and M.luteus (Gram positive bacterium) for 24 
and 48 hours of culture in presence of nanoparticles and nanocapsules. 
In the case of E. coli, the bacterium is especially sensitive to the antibacterial 
action of triclosan. At 24 hours of culture, the inhibition of bacterial growth was 
about 80%, and occurs with both nanospheres and nanocapsules. This antibacterial 
effect occurs when about 50% and 80% of triclosan was released from the 
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nanocapsules and nanospheres, respectively. The triclosan released ensures that at 
48 hours of culture, the inhibition of bacterial growth remains around 80%. 
The M. luteus bacterium shows greater resistance to triclosan, thus inhibiting 
its growth was only about 20% and 10% at 24 hours of culture for nanospheres and 
nanocapsules, respectively. However, a significant increase in bacterial growth 
inhibition between 24 hours and 48 hours of culture was observed, and the 
nanospheres caused 40% of growth inhibition, and for the nanocapsules was of 20%; 
i.e., the relative inhibition of bacterial growth was doubled as the drug release is 
increased. In this way, it is possible to expect that with progressive release of the 
triclosan from nanospheres and nanocapsules, an increase of the antibacterial effect 
occurs. 
 
 
Figure 6.7. Relative growth (%) of bacteria gram negative (white bars) and gram positive (grey 
bars) in presence of nanospheres and nanocapsules loaded with triclosan.  
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Figure 6.8 shows the antimicrobial effect of the nanospheres and nanocapsules 
in relation to quantity of material (it has been handled by dilution). Logically, there 
is a direct linear relationship between the antibacterial effect and the amount of 
nanospheres and nanocapsules loaded with triclosan, with R2 of 0.987 and 0.999, 
respectively. 
 
 
Figure 6.8. Effect on relative growth of nanospheres (white bars) and nanocapsules (grey bars) 
according to the dilution ratio between nanoparticle suspension (material) and the bacteria 
suspension (culture medium). 
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7. Conclusions 
This thesis is focused on a multidiscipline study of a new system to produce 
nanocapsules for pharmaceutical application. The system under investigation 
comprises a new amphiphilic polymer from polyalkylcyanoacrylates family, 
modified with polyethylene glycol chains, named poly(methoxypolyethylene glycol 
cyanoacrylate-co-hexadecylcyanoacrylate), and micromixers used in nanosphere 
and nanocapsule production. 
 
The polymer, that should be better referred to as a copolymer, is not a 
commercial product: it is synthesized in laboratory and it is here characterized from 
the physicochemical point of view. This characterization showed the copolymer 
have a particular behaviour due to the presence of the two domains. The low fusion 
point and rapid degradability in water explains the difficulties in its manipulation 
and highlights its technological characteristics. 
 
Nanocapsules were produced by confined impinging jets mixers (CIJMs) and 
results were compared with nanospheres. CIJMs have been already studied in 
nanosphere production.  Here they are used for nanocapsule production and results 
are compared with previous investigation on nanospheres. CIJMs were successfully 
used in nanocapsule production: main parameters are investigated and evaluated 
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and, finally, compared with the previous results on nanospheres. Nanocapsules 
have a more complicated mechanism of formation and more parameters have to be 
taken into account for their precipitation in CIJMs. Different geometries were 
investigated and scale up criteria have been proposed. 
 
Nanocapsules and nanospheres have been characterized using advanced 
techniques, such as X-ray photonelectron microscopy (XPS) and transmission 
electron microscopy (TEM). XPS results showed some differences in surface 
chemical composition between nanospheres and nanocaspules. Measurements at 
variable angles have been performed in order to investigate the composition of the 
external layers and esteem polymer wall thickness. TEM analysis have been carried 
out in order to see the products and investigate the two structures. TEM 
investigation confirmed the oil is inside the nanocapsules.  
 
Nanospheres and nanocapsules were loaded with a lipophilic drug as model 
drug. Drug loading and incorporation were very high in both the systems. Drug 
release experiments highlighted a slower release from nanocapsules, due to the 
great affinity of the lipophilic drug to the inner core. Antibacterial activity texts 
confirmed the activity of the drug and the mantaining of the antibacterial activity of 
the drug even after the incapsulation. 
 
If we assume a formulation with 10 mg/ml of polymer and a concentration in 
active principle of 1 mg/ml (10% of polymer amount) with an injection pump which 
can reach a flow rate of 300 ml/min the total productivity it will be around 0.2 
kg/h. It should be possible also to use many mixers in parallel: hypothesizing to use 
10 mixer in parallel the productivity becomes 2 kg/h, whit 10% of active principle. 
These numbers match with the usual amount of pharmaceutical industry.  
 
To conclude this system is suitable to produce both nanospheres and 
nanocapsules. Main problems are related to the manipulation of the polymer and to 
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its chemical characteristics. More investigation about its residual solubility and the 
effective PEG amount on the surface are necessary in order to optimize the process. 
Most of these remaining questions are due the mass quantification of the polymer 
available for the precipitation and, in particular in case of nanospheres, the 
determination of the real structure of the loaded particle. 
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